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ABSTRACT 
 
 
Seasonal Influenza Vaccination Disparities Between  
U.S. Non-Hispanic Whites and Hispanics, 2000-2009 
 
by 
 
 
Andrew E. Burger, Master of Science 
Utah State University 2011 
 
 
Major Professor: Dr. Eric Reither 
Department: Sociology 
 
Seasonal influenza produces substantial disease within the United States every 
year. Despite the availability of safe and effective vaccines for influenza, millions of 
individuals go unvaccinated each flu season, with notable differences across racial/ethnic 
groups. Using the Behavioral Risk Factor Surveillance System (BRFSS), I examine 
vaccination rates among non-Hispanic whites and Hispanics during the 2000-2009 
influenza seasons. After developing a new method that addresses shortcomings of BRFSS 
vaccination measures, I find that non-Hispanic whites exhibit higher vaccination rates 
than Hispanics. Through a series of logistic regression models I show that the disparities 
between non-Hispanic whites and Hispanics narrow after controlling for healthcare 
coverage and socioeconomic characteristics. This suggests that seasonal influenza 
vaccination may be improved among U.S. Hispanics by addressing structural barriers in 
receiving the vaccine, especially access to health care.  
 (83 pages) 
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PUBLIC ABSTRACT 
 
Seasonal Influenza Vaccination Disparities Between  
U.S. Non-Hispanic Whites and Hispanics, 2000-2009 
  
by 
 
Andrew E. Burger, Master of Science 
Utah State University 2011 
 
The seasonal flu is a deadly disease which infects millions of individuals within the 
United States annually. One of the leading causes of death in the United States, the 
seasonal flu claims more lives than liver disease, homicide, or HIV. While most 
individuals will not develop life-threatening symptoms due to the seasonal flu, millions 
of individuals become sick every year. Not only does this produce hundreds of thousands 
of hospitalizations annually, but also creates a drain on the economy as individuals are 
not able to attend their daily activities. This burden remains despite the presence of safe 
and effective seasonal influenza vaccines. Backed by numerous studies, the seasonal flu 
vaccine has been found to be the most effective means of preventing infection. The 
Centers for Disease Control and Prevention (CDC) recommends that everyone 6 months 
of age and older become vaccinated.  
 
However, despite the effectiveness of the seasonal flu vaccine, the disease burden 
associated with the seasonal flu remains. Part of the reasons for the continuing costs of 
the seasonal flu is due to the consistent racial and ethnic gaps in the receipt of the 
seasonal flu vaccine. Previous studies have found that racial and ethnic minorities receive 
the influenza vaccine at lower rates than non-Hispanic whites. Since most of these studies 
look at vaccinations during a particular flu season, little is known about the overall trends 
in vaccination among the population. 
 
This thesis looks specifically at trends in vaccination uptake among non-white Hispanics 
and Hispanics in the United States during the 2000-2009 flu seasons. Using data from the 
Behavioral Risk Factor Surveillance System (BRFSS), I present a new method of 
organizing respondents to more accurately track vaccination during a specific flu season. 
I then examine differences in non-Hispanic whites and Hispanics in their influenza 
vaccination behavior.  
 
During this time period I find that while both groups experienced upward trends in 
vaccination uptake, non-Hispanic whites are doing so at a quicker pace than Hispanics 
leading to an increasing gap between the two groups. I find that Hispanics experience 
lower odds of receiving a vaccine than non-Hispanic whites. But when controlling for 
socioeconomic factors, odds of reporting a flu vaccine increase substantially. Having 
some form of healthcare coverage was found to be a powerful predictor increasing the 
odds of receiving a flu vaccine. This suggests that by increasing healthcare coverage 
among the U.S. Hispanic population, gains in influenza vaccination could occur.   
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CHAPTER I 
INTRODUCTION 
 
First recorded in 1504, the term influenza is most likely derived from the Italian 
word meaning ―influence‖ (Quinn 2008). It was believed by the Italians at the time that 
influenza, or more commonly known as the ―flu,‖ was brought about by the ―malevolent 
position of the stars at certain times‖ (40). The influenza virus has likely affected humans 
for our entire known history. As early as the 4
th
 century BC, the famous Greek physician 
Hippocrates gave an account of perhaps the first recorded influenza epidemic. 
Hippocrates (whose oath of medical ethics still impacts physicians today) described a 
condition where many, especially children, experienced convulsions, fevers, coughs, and 
great pain (42).  
The seasonal flu is dangerous not only in its ability to produce significant 
mortality and morbidity burdens within local populations, but also by its ability to mutate 
into novel (or new) strains of influenza, capable of spreading across the globe. It is 
generally agreed that the first influenza pandemic occurred in 1580 where, in a period of 
6 months, an influenza strain spread through the ―whole of Europe,‖ with infection 
eventually spreading to the Americas (Potter 2001:574). While seasonal influenza 
epidemics continued, the next pandemic wave would not occur for almost another 80 
years (Quinn 2008). The 1658 pandemic was of such serious proportions that it would be 
reported by ―many writers and commentators, [and] not just physicians‖ (Quinn 
2008:52). Dr. Willis, one such commentator of the time, wrote his account of the 1658 
pandemic, describing patients who were ―troubled with burning thirst, waking, 
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hoarseness, and coughing, almost continual‖ (52–53). Dr. Willis notes that while most of 
the younger men recovered, among those advanced in age ―not a few died of it‖ (53).  
 As human mobility increased throughout the world and international trade 
stretched across the globe, so did the ability of influenza to spread and infect populations. 
The influenza pandemic of 1781 is considered by historians to be ―among the greatest 
manifestations of the disease in all history‖ (Quinn 2008:71). The first outbreak was 
believed to have begun in China, then spreading through Russia, continued to encompass 
Europe in the space of 8 months (Potter 2001). It is estimated that at the peak of this 
pandemic ―30,000 fell ill each day in St. Petersburg [and] two-thirds of the population of 
Rome became ill‖ (575). It should be noted that even without modern advances in 
transportation, influenza was able to spread quickly throughout most of the world.  
The next serious outbreak of influenza occurred in 1830. Following the same path 
as the 1781 pandemic, the 1830 pandemic began in China and then spreading through 
Russia to Europe eventually spread through the Americas (Patterson 1986). Although 
quantitative data were rare during the pandemic of 1830, contemporary ―observers 
consistently reported high morbidity and low case-mortality‖ (Patterson 1986:35). During 
the 1830 pandemic, medical treatment still relied on archaic medical practices such as 
bloodletting (Quinn 2008). 
While these 18
th
 and 19
th
 century pandemics were devastating and killed millions, 
they pale in comparison to the damage inflicted by the most severe influenza pandemic 
recorded to date, the 1918 influenza pandemic commonly known as the ―Spanish Flu.‖ 
Health records were considerably more accurate during the 1918 pandemic than in past 
outbreaks, but much remains unknown as to its full effect on mortality. Considered an 
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example of the possible ―upper bound on the number of deaths caused by [a] future 
pandemic‖, the 1918 influenza was devastating (Murray et al. 2007). Johnson and 
Mueller (2002) comment that while ―it would seem unlikely that a truly accurate figure 
can ever be calculated,‖ the total mortality caused by this pandemic ―may fall in the range 
of 50 to 100 million‖ (115). 
Fortunately, since 1918 the world has not experienced another influenza 
pandemic of similar magnitude. However, every year in the United States seasonal 
influenza epidemics cause thousands of deaths, even more hospitalizations, and drain 
billions of dollars from the economy. Fortunately, medical advances have produced 
effective treatments to counter the symptoms of seasonal influenza, as well as the means 
to prevent it altogether through vaccinations. However, because many do not receive 
seasonal vaccinations, a substantial disease burden attributable to the flu is experienced 
within the United States every year.  
 
Racial and Ethnic Disparities in Influenza Vaccination 
Consistently, racial and ethnic disparities in receipt of the seasonal influenza 
vaccine have been observed especially among Hispanics (Lu et al. 2008). Reduction in 
these disparities could provide substantial health benefits not only to racial and ethnic 
minorities, but to the entire population. This thesis will focus on influenza vaccination 
disparities between non-Hispanic whites and Hispanics in the United States. Given that 
Hispanics are now the largest and fastest growing ethnic minority group in the United 
States (Pew Hispanic Center 2011a), understanding public health challenges in this 
population is of great importance. However, much attention has been given to the 
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―Hispanic paradox‖ where Hispanics, even with their average lower socioeconomic 
status, experience a mortality advantage over other similarly disadvantaged racial/ethnic 
minority groups (Markides and Coreil 1986).  
 
The Hispanic Paradox 
First documented in 1986, the Hispanic Paradox proposed that Hispanics 
experienced similar health outcomes to non-Hispanic whites despite their lower 
socioeconomic status (Markides and Coreil 1986). This discovery was viewed as a 
―paradox‖ since lower socioeconomic status has traditionally been viewed as a predictor 
of poorer health, as is often observed among disadvantaged African Americans. Despite 
research questioning the existence of a ―Hispanic paradox‖ (Smith and Bradshaw 2006), 
evidence does suggest that a mortality advantage exists at least for some Hispanic groups 
(Markides and Eschbach 2005). Questioning biological explanations for a mortality 
advantage among Hispanics, Palloni and Arias (2004) present evidence that the ―Hispanic 
paradox‖ was not really attributable to all Hispanics, but may rather be a characteristic 
found only among foreign-born individuals from Mexico. Explaining the paradox among 
foreign-born Mexican nationals in the United States, Palloni and Arias (2004) emphasize 
a ―salmon-bias‖ effect where return migration of ill foreign-born Mexicans artificially 
deflates Hispanic mortality. If the Hispanic mortality advantage is explained through such 
factors as the return migration of its sick members or the selective emigration of healthy 
individuals, then future health concerns arise given the shift from migration to natural 
birth as the main driver in Hispanic population growth (Suro and Passel 2003).  
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A recent report from the Pew Hispanic Center (2011b) notes 58 percent of the 
growth experienced by U.S. Hispanics came from natural births rather than immigration. 
It is likely that this proportion will increase with studies showing rates of migration into 
the United States slowing from countries such as Mexico (Passel and Cohen 2010). This 
shift in growth from immigration to natural increase should be noted by public health 
officials given that ―U.S-born Hispanics tend to be less healthy than Hispanic 
immigrants‖ (Livingston, Minushkin, and Cohen 2008:10). Even if a mortality advantage 
does exist among Hispanics, Markides and Eschabach (2005:74) note that 
[…] it would be unfortunate if public health policy overlooked the presence of 
clear and remediable disparities in health care access and the burden of infectious 
diseases, diabetes, and disability that clearly do disadvantage Hispanics, even 
should it prove that some compensating factors create offsetting advantages in 
other morbidity and mortality processes.  
 
 With the growth among U.S. Hispanics changing from immigration to natural  
increase, the observed ―Hispanic paradox‖ may disappear as a greater number of 
Hispanics are U.S. born, revealing poorer health among this population. Furthermore, 
supporting evidence of health disadvantages among Hispanics was found during the 2009 
H1N1 influenza pandemic; the CDC noted that even though Hispanics represent 15 
percent of the U.S. population, nearly 30 percent of A(H1N1) cases during the early 
spring wave were among Hispanics (CDC 2010g). Further evidence of a possible 
Hispanic health disadvantage during the 2009 A(H1N1) pandemic is found in a study 
which, following a group of infected individuals admitted into an intensive care unit 
(ICU) in Utah for A(H1N1), found that Hispanics were disproportionally affected by the 
disease suggesting perhaps a ―genetic predisposition for a more severe manifestation of 
A(H1N1) infection‖ (Miller et al. 2010:756). These disturbing trends suggests that 
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Hispanics may actually experience higher risks of infection for certain strains of 
influenza. Whether those risks are attributable to biological or sociodemographic factors 
has yet to be fully determined. Essentially, ―the need to address observed health 
disparities concerning Hispanics does not turn on how the Hispanic paradox is finally 
explained‖ (Markides and Eschabach 2005:74). Given the relative ease with which 
influenza vaccinations can be produced and administered, it is one such ―clear and 
remediable‖ health disparity that should be addressed.  
 
Outline of Thesis  
To evaluate seasonal influenza vaccination disparities between non-Hispanic 
whites and Hispanics, it is important to monitor trends in vaccination rates. While 
previous research has identified disparities within particular flu seasons (Jones et al. 
2004; Link et al. 2006), few studies have tracked disparities across multiple influenza 
seasons (see Lu et al. 2008). In order to emphasize the need for tracking influenza 
vaccination coverage and the potential health gains vaccination could have on society, a 
review of the mortality, morbidity, and economic burden of seasonal influenza will be 
presented in Chapter II. Following, a brief review of the literature detailing the 
effectiveness of the seasonal influenza vaccine in preventing disease will be given. To 
help explain the mechanisms behind racial and ethnic disparities in seasonal influenza 
vaccinations, this study utilizes the Fundamental Cause Theory (FCT), which proposes a 
central relationship between socioeconomic status (SES) and health outcomes, as 
outlined in Chapter III. A detailed description of the method used to estimate seasonal 
vaccination rates with the Behavioral Risk Factor Surveillance System (BRFSS) will be 
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given in Chapter IV with a subsequent comparison utilizing the National Health 
Interview Study (NHIS). This method, which utilizes the respondent‘s month of 
interview to more accurately calculate seasonal vaccination, will be compared with 
previously employed methods. Using this method, seasonal vaccination rates among non-
Hispanic whites and Hispanics will be estimated. This and other descriptive results will 
be presented in Chapter V. To test the propositions set forth by FCT, a series of logistic 
regression analyses will be performed to control for SES and its influence on the odds of 
reporting receipt of a seasonal influenza vaccination between non-Hispanic whites and 
Hispanics. Chapter VI presents the results of these analyses, along with my interpretation. 
Additionally, the academic and policy implications of this research are discussed. 
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CHAPTER II 
DISEASE BURDEN OF SEASONAL INFLUENZA 
 
 Given the potential for seasonal influenza to infect large portions of society every 
year, its burden is often substantial in terms of mortality, morbidity and related economic 
costs. Influenza is a leading cause of death in the United States with an estimated 263,887 
cumulative deaths occurring during the 1999 through 2006 influenza seasons (CDC 
2010a). This mortality estimate places influenza above deaths caused by liver disease 
(245,869), hypertension (192,290), homicide (161,747), and HIV (120,222) during the 
same time period (CDC 2011b). A brief description of the mortality, morbidity, and 
economic burden of seasonal influenza is provided to emphasize the destructive nature of 
this common virus, and to stress the need for more effective seasonal vaccination 
programs of the population.  
 
Mortality Burden of Seasonal Influenza  
In a recent publication on mortality trends due to seasonal influenza from 1976 to 
2007, the Centers for Disease Control and Prevention (CDC) estimates that, on average, 
seasonal influenza is responsible for 23,607 deaths each flu season (CDC 2010a). 
However, this average masks variability in the virulence of seasonal influenza and the 
dramatic variation in mortality that can occur based on virus type (CDC 2010a). 
Consistently, in flu seasons where the influenza A(H3N2) virus is present, mortality is 
2.7 times higher than when that particular virus type is absent (CDC 2010a). It is not 
surprising, then, to learn that the 2003 influenza season (in which A(H3N2) virus was 
present) is estimated to have the highest impact on mortality in the 30 year period of 
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observation, with an estimated 48,614 deaths attributable to the A(H3N2) influenza virus 
(CDC 2010a). In contrast, the 1986 influenza season was estimated to have the lowest 
number of influenza related deaths with 3,349 (CDC 2010a). Molinari et al. (2007), in 
examining mortality from 2001 through 2003 (years dominated by the more virulent type 
A(H3N2) virus), estimate that 610,660 life-years are lost per annum in the United States 
due to seasonal influenza. 
 
Morbidity Burden of Seasonal Influenza 
Given the substantial mortality burden associated with seasonal influenza, it is not 
surprising that the morbidity burden is also large. However, unlike mortality associated 
with seasonal influenza, which is measured by number of deaths, the morbidity burden is 
more difficult to calculate. A useful gauge to help understand the severity of seasonal 
influenza in producing morbidity is to approximate the number of hospitalizations 
attributed to seasonal influenza. While not providing an approximation for the total 
number of illnesses caused by influenza, calculating the number of hospitalizations 
attributable to seasonal influenza does provide an insight to its virulence. In Thompson et 
al. (2004), the annual number of hospitalizations caused by seasonal influenza is 
estimated for the 1979 through 2000 flu seasons. During the time period, it was projected 
that on average 226,000 individuals were hospitalized per flu season (Thompson et al. 
2004). However, just as is the case with mortality estimates, this average masks 
variability that can exist in the virulence of influenza. For example, during the 1997 flu 
season (in which an influenza type A(H3N2) virus was dominant) approximately 430,960 
hospitalizations were attributed to influenza-related illnesses, while the 1990 flu season 
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experienced an estimated 157,911 hospitalizations due to seasonal influenza (Thompson 
et al. 2004). Also, seasonal influenza can aggravate chronic health conditions, such as 
cardiovascular disease, producing further hospitalizations (Madjid et al. 2007).  
Hospitalizations caused by influenza may be a useful way to gauge morbidity 
burden, but they certainly underrepresent the full effect of seasonal influenza on the 
health of a population. The vast majority of individuals infected by seasonal influenza 
will not develop life threatening complications requiring hospitalization, but rather mild 
symptoms including fever, coughing/sore throat, runny nose, and body aches (U.S. 
Department of Health 2011). While these symptoms may be minor and the effect on the 
individual temporary, the sheer number of people infected by seasonal influenza can 
create disruptions throughout society. Given the large mortality and morbidity burden 
associated with seasonal influenza, the economic burden of influenza is also substantial.  
 
Economic Burden of Seasonal Influenza  
Molinari et al. (2007) calculate that, on average, seasonal influenza is responsible 
for an annual economic burden of nearly $87.1 billion (in 2003 dollars). Of this estimated 
economic burden, nearly 88 percent is attributable to indirect costs of illness (e.g., lost 
wages due to illness or death), while the remaining 12 percent is associated with medical 
treatments for seasonal influenza. Furthermore, an estimated 44 million days of work are 
lost each year because of influenza-related illnesses (Molinari et al. 2007). This seasonal 
absenteeism can have substantial effects in terms of cost for employers and employees 
resulting in an overall drain on the economy (Akazawa, Sindelar, and Paltiel 2003).  
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It is interesting to note that the average economic burden of one year of seasonal 
influenza (when adjusted for inflation to 2011 dollars), as presented in Molinari et al. 
(2007), is greater than the total economic damage caused by major natural disasters 
(including floods, hurricanes, fires, droughts, tornados and tropical storms) from 2006 
through 2009 (National Climatic Data Center 2011). However, unlike hurricanes, the 
large mortality, morbidity, and economic burdens of seasonal influenza can easily be 
reduced through an effective vaccine. 
 
Effectiveness of Influenza Vaccination 
In the 2010 flu season, the CDC began recommending that everyone over 6 
months of age should receive a seasonal influenza vaccine (CDC 2010a). This change 
reflects a shift in policy emphasizing the need for universal influenza vaccination 
coverage. The modification in policy is based in research showing the health benefits 
individuals, and the population as a whole, can achieve through vaccination (CDC 
2010e). The CDC recommends that receiving a seasonal influenza vaccine should be the 
first step in preventing the flu (CDC 2010d). In fact, substantial efforts have been taken 
by the United States government to promote general knowledge regarding seasonal 
influenza and the benefits of vaccination. For instance, the internet website, www.flu.gov, 
provides information regarding the seasonal flu and where individuals can obtain an 
influenza vaccination. 
The recommendation comes from strong evidence showing the effectiveness of 
the influenza vaccine in preventing illness (Bridges et al. 2000; Hak et al. 2005). Despite 
a minority of reports questioning the efficacy of the seasonal influenza vaccine (Jefferson 
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2006; Simonsen et al. 2005), the majority of studies have found that influenza 
vaccination in general is a highly effective means of preventing influenza-related illness. 
Influenza vaccination has been shown to reduce disease among mothers and young 
infants (Zaman et al. 2008) and in healthy children (Jefferson et al. 2005; Manzoli et al. 
2007). Benefits are also available for healthy working adults, with the influenza vaccine 
reducing upper respiratory illness by an estimated 25 percent and further reducing work 
absenteeism due to upper respiratory illness by another 43 percent (Nichol et al. 1995). 
Seasonal vaccination also provides benefits to the elderly population, who may be more 
at risk of infection than the general populace (Gross et al. 1995, Nichol et al. 2007). Even 
when the influenza vaccine, which is prepared before the onset of the flu season, is a poor 
antigenic match for a particular strain of seasonal influenza, some level of protection can 
still be acquired through vaccination (Herrera et al. 2007; CDC 2010d).  
 Yet reaching the new levels of vaccination recommended by the CDC will prove 
difficult. Prior to the 2010 flu season, the CDC recommended influenza vaccination for 
those members in the population at particular risk for influenza related complications, 
such as the elderly or those with chronic health conditions (Lu et al. 2008). However, in a 
study of vaccination uptake from 1988 through 2004, even for those high-risk groups, 
estimated vaccinations were lower than their established goals sometimes by as much as 
an absolute value of 30 percent (Lu et al. 2008).  
 
Disparities in Receipt of Seasonal Influenza Vaccination 
 An important force in sustaining the large mortality, morbidity, and economic 
burden of seasonal influenza in the United States is the scope of racial and ethnic 
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disparities in the receipt of seasonal influenza vaccines. Consistently, lower proportions 
of racial and ethnic minorities report influenza vaccination relative to non-Hispanic 
whites (Egede and Zheng 2003; Rangel et al. 2005; Link et al. 2006; Chen et al. 2007; 
Logan 2009; Linn, Guralnik, and Patel 2010; Burger et al. forthcoming).  
 Racial and ethnic disparities are so great that Fiscella (2005) suggests that if 
elderly Hispanic and African Americans were vaccinated at the same rates as elderly non-
Hispanic whites, it would result in an additional 1 million elderly racial/ethnic minority 
persons being vaccinated each year. Furthermore, Fiscella et al. (2007) estimate that an 
average of 33,000 years of life could be saved each year among elderly racial and ethnic 
minorities by eliminating disparities in seasonal influenza vaccination.  
The reasons for such disparities are likely to be complex. Among the explanations 
for racial and ethnic differences in influenza vaccination are theories regarding ―attitudes 
toward vaccination and preventative care‖ (Lu et al. 2008:1791), differences in exposure, 
susceptibility and treatment (Blumenshine  et al. 2008), and structural barriers such as 
lack of health insurance (Chen et al. 2007). Racial and ethnic minorities may also have 
less access to information regarding seasonal influenza and the benefits of vaccination 
(Hebert et al. 2005). In analyzing the reasons cited by racial and ethnic minorities for not 
receiving an influenza vaccination, Chen et al. (2007) found that one of the most common 
explanations was lack of concern about contracting the seasonal flu. This lack of concern 
regarding the receipt of a seasonal influenza vaccine comports with additional research 
showing racial and ethnic minorities may be less likely to go to a health care facility with 
the sole intent of receiving an influenza vaccination (Link et al. 2006).  
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Influenza Vaccination among U.S. Hispanics 
 Particularly large and persistent disparities in the receipt of seasonal influenza 
vaccinations have been observed between Hispanics and non-Hispanic whites in the 
United States (Rangel et al. 2005; Linn, Guralnik, and Patel 2010; Burger et al. 
forthcoming). Lu et al. (2008:1791) found that non-Hispanic whites were ―persistently 
more likely to be vaccinated than […] Hispanics among persons aged ≥65 years, high-
risk persons aged 18 through 64 years, health care workers, and household contacts.‖ 
These observations indicate that this potentially vulnerable population may face 
significant barriers to acquiring adequate levels of vaccination. In addition to the 
previously mentioned barriers to vaccination often experienced by racial and ethnic 
minorities, language barriers can also deter vaccination among Hispanics (Chen et al. 
2007). Supporting evidence toward a language barrier in vaccination, Fiscella et al. 
(2002) finds that English-speaking Hispanics with health insurance did not differ 
significantly from their non-Hispanic white counterparts in terms of receiving an 
influenza vaccination. However, they found that Spanish-speaking Hispanics with health 
insurance received flu vaccinations at lower rates than non-Hispanic whites with 
insurance, emphasizing possible language barriers in vaccination.  
In addition, preventive healthcare services, such as the seasonal flu vaccine, are 
often underutilized by Hispanics (Kang-Kim et al. 2008; Logan 2009). Chen et al. (2007) 
found that Hispanics often cite structural barriers to flu vaccination, such as insufficient 
access to healthcare services, lack of transportation, and economic costs. Insurance is also 
found to be a factor that influences preventive care among Hispanics (Chen et al. 2007; 
DuBard and Gizlice 2008; Burger et al. forthcoming). 
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Given the magnitude of the disparity among racial and ethnic minorities 
(especially among Hispanics) in receiving a seasonal influenza vaccine, it will be useful 
to examine these inequalities through a theoretical lens. To help explain the observed 
disparity in influenza vaccination between Hispanics and non-Hispanic whites in the 
United States, this study will utilize the concepts and propositions as set forth in the 
Fundamental Cause Theory (FCT) as presented by Link and Phelan (1995). The FCT not 
only provides a useful theoretical framework for explaining Hispanic inequalities in 
influenza vaccination, it also establishes propositions that are easily testable. In the 
following chapter, a detailed description of FCT is given, as well as an explanation for 
influenza vaccination patterns among U.S. Hispanics. 
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CHAPTER III 
THEORY 
 
In 1995, Link and Phelan presented their seminal theory explaining health 
disparities in their article entitled, ―Social Conditions as Fundamental Causes of 
Disease.‖ This article provides the groundwork for what would come to be known as 
Fundamental Cause Theory (FCT). FCT grew out of a reaction from social 
epidemiologists and sociologists alike to the popular ―blame the victim‖ approach of 
addressing health inequalities in the United States during the 1980s (Link and Phelan 
1995). During this time period, medical and social researchers more commonly looked 
for proximate causes of disease and sought ways to address disease through those causes 
rather than recognizing the underlying structural issues. For example, with the knowledge 
that lung cancer was associated with cigarette smoking, public and private campaigns 
urging individuals to quit smoking emerged. Since smoking was seen as controllable at 
the individual level, it ―resonates with the value and belief system of Western culture that 
emphasize[s] both the ability of the individual to control his or her personal fate and the 
importance of doing so‖ (Link and Phelan 1995:80). However, this approach fails to 
recognize that behind smoking, a proximate cause of lung cancer, are various 
socioeconomic conditions that promote the behavior. Barbeau, Krieger, and Soobader 
(2004) found that class plays a significant role in rates of smoking and cessation, with 
higher socioeconomic status individuals being able to utilize more resources to help them 
quit smoking or avoid it altogether. 
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Given the focus on personal health behaviors, broader social explanations of 
health fell out of favor. Link and Phelan (1995) emphasize that societal explanations of 
health, such as a SES-health association, have been re-contextualized to minimize their 
importance. First, researchers may disregard societal forces as being merely proxies of 
disease. Citing evidence of this belief, Phelan et al. (2004:266) note that in the widely 
read Modern Epidemiology (1986) by Kenneth J. Rothman, socioeconomic status was 
considered to be ―casually related to few if any diseases but is a correlate of many causes 
of disease‖ (90). Other times, researchers ignore social forces and rather ―focus on 
mechanisms that mediate between socioeconomic status and mortality in the hopes of 
reducing mortality disparities by intervening on those mechanisms‖ (Phelan et al. 2004). 
Furthermore, the role of socioeconomic status is diminished by researchers considering it 
merely a ―starting point‖ from which they could pursue the more proximate causes of 
disease.  
 As the name of the theory states, FCT posits that social conditions may be the 
―fundamental cause‖ of disease (Link and Phelan 1995). By fundamental cause, Link and 
Phelan refer to the social conditions that influence health outcomes, and ―cannot be 
eliminated by addressing the mechanisms that appear to link them to disease‖ (86). This 
point is often demonstrated by using a simple path diagram (Figure 1), which shows the 
purported relationships between SES, proximate risk factors, and health outcomes.  
According to Phelan and Link (2005), traditional epidemiology suggests that if 
the proximate risk factors were held constant, the association between socioeconomic 
status and health would be greatly diminished, if nonexistent.  
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However, as Phelan and Link (2005) describe, history provides examples of when 
proximate risk factors have been addressed, yet the association between socioeconomic 
status and health remains. During the 19
th
 century, the major causes of death were 
primarily related to infectious diseases such as cholera, smallpox, and tuberculosis. Also 
during this period, intense industrialization and urbanization occurred resulting in 
population centers which were often overcrowded and lacked sanitary means of 
providing clean water and disposing of waste. As Szreter (1988) notes, these health 
hazards were addressed, as adequate housing and clean water were provided. As a 
consequence, mortality from infectious diseases diminished. Phelan and Link (2005) note 
that with the disappearance of those proximate causes of disease (i.e., poor housing and 
contaminated water), the link between SES and health should have also disappeared. 
Still, the association between SES and health continued. Phelan and Link (2005) propose 
that the failure of eliminating poor health outcomes by addressing their proximate causes 
was due to the fact that 
new risk factors (such as chemical pollutants) arose, new knowledge about risk 
factors (such as smoking) emerged, and new treatment technologies (such as 
medicines that reduce cholesterol) were developed, and those possessing the most 
resources were best able to avoid the new risks and take advantage of the new 
protective factors, resulting in the emergence of a socioeconomic gradient in these 
factors. (29) 
 
 
Socioeconomic 
Status 
Proximate Risk 
Factors 
Health 
Outcomes 
FIGURE 1. Causal Diagram Outlining Relationship Between 
Socioeconomic Status and Health Outcomes.  
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Indeed, if ―no new diseases emerged (such as AIDS), [and] no new risks 
developed (such as pollutants), no new knowledge about risks emerged […]‖ then ―the 
concept of fundamental social causes [of disease] would not apply‖ (Link and Phelan 
1995:87). Essentially, fundamental causes of disease ―involve access to resources that 
can be used to avoid risks or to minimize the consequences of disease once it occurs‖ 
(87).  
Link and Phelan (1995) also make the case that race and ethnicity is often ―so 
closely tied to resources like money, power, prestige, and/or social connectedness that 
they should be considered as potential fundamental causes of disease […]‖ (87). 
According to FCT, because health risks are constantly emerging, economically 
advantaged individuals, who may be stratified by race/ethnicity, will be better able to 
utilize resources to experience a more favorable social condition from which to address 
health risks.  
 
Flexible Resources 
The concept of ―flexible resources‖ is important in FCT and is conceptualized 
broadly as ―money, knowledge, power, prestige, and the kinds of interpersonal resources 
embodied in the concepts of social support and social network‖ (Link and Phelan 
1995:81). These resources include relationships with friends, family, coworkers, and to 
those whose roles fall within broader societal structures. It is the relationship between 
such flexible resources and fundamental causes of disease that prevent health disparities 
from being eliminated by addressing only the proximate causes of disease. In an 
environment of competition for scarce resources (such as health), those with the most 
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knowledge and power will be advantaged in acquiring those resources. Furthermore, FCT 
also proposes that the use of flexible resources is for the benefit of its members and is 
done so in a ―purposeful‖ manner (Phelan et al. 2004:268). Examples of such actions or 
resources used intentionally to promote health among the socioeconomically advantaged 
include, ―asking for beneficial health procedures; quitting smoking; getting flu shots; 
wearing seat belts and driving a car with airbags; eating fruits and vegetables; exercising 
regularly and taking restful vacation‖ (Phelan et al. 2004:267). Since the use of such 
resources is purposeful, better health outcomes are not merely a ―coincidental side-effect 
of ‗the good life‘‖ (Phelan et al. 2004:268).  
 
Fundamental Causes of Disease 
In summarizing the fundamental social causes of disease, Phelan et al. (2004) 
describe first the fundamental causes‘ ability to ―influence multiple disease outcomes‖ 
(280). Indeed, the social causes of morbidity and mortality are not limited to a single 
disease. For example, Everson et al. (2002) found low SES to be related to higher risk of 
depression, obesity, and diabetes. Secondly, fundamental causes can also affect disease 
outcomes through a variety of risk factors. Thirdly, the ―association between the 
fundamental cause and mortality is reproduced over time via the replacement of 
intervening mechanisms‖ (Phelan et al. 2004: 268). As mentioned previously, if new 
risks to human health do not emerge, then the economically advantaged would not be 
able to use their flexible resources to reduce risks of negative health outcomes.  
Finally, the ―essential feature‖ of fundamental causes in disease is that they 
―involve access to resources that can be used to avoid risks or to minimize the 
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consequences of disease once it occurs‖ (Phelan et al. 2004:268). An excellent example 
of this utilization of resources by the socioeconomically advantaged to offset health risks 
can be found in Victora et al. (2000). In analyzing differences in infant mortality rates 
(IMR) among Brazilian children, disparities were observed between the 
socioeconomically advantaged and the poor. In two different cities, it was found that the 
economically advantaged were better able to utilize public-health programs designed to 
reduce infant mortality. The remarkable decline in infant mortality rates among the 
economically advantaged led Victora et al. (2000:1098) to conclude that ―an increasing 
proportion of the rich were making use of newer technologies that were still unavailable 
to most of the poor.‖ 
 Important in understanding the implications of the fundamental cause perspective 
in describing racial and ethnic disparities is the ability of a given society to control a 
disease. Phelan and Link (2005) argue that the ability of a society to control disease and 
death is just as important for the creation of health disparities as the unequal distribution 
of resources. This ―core‖ proposition of FCT posits that ―It is our enormously expanded 
capacity to control disease and death in combination with existing social and economic 
inequalities that create health disparities by race and SES‖ (29). So, new techniques or 
knowledge in promoting health are ―distributed according to resources of knowledge, 
money, power, prestige, and beneficial social connections‖ (29). This means that health 
―disparities by SES and race should emerge when new health enhancing information or 
technology is developed‖ (30). 
Following the FCT perspective, disparities in flu vaccinations are likely to be 
observed between non-Hispanic whites and Hispanics; given that non-Hispanic whites 
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may be better able to utilize their higher socioeconomic status in applying flexible 
resources to maximize health benefits. However, controlling for flexible resources that 
encourage vaccination should attenuate this ethnic disparity in vaccination for seasonal 
influenza. This is an expected outcome since there is nothing fundamental about race or 
ethnicity per se that leads to poorer health outcomes; instead, race and ethnicity tend to 
predict disease because of the flexible resources associated with it. Before analyzing 
2001 through 2010 BRFSS data for these possible disparities, I will discuss my strategy 
to manipulate BRFSS data in a manner that yields accurate seasonal influenza 
vaccination estimates.  
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CHAPTER IV 
METHODS AND ANALYSES 
 
The ability to monitor a population‘s health is of critical importance in 
maintaining a healthy and productive society. Without proper health information, 
addressing health issues to reduce mortality and morbidity burdens within a population is 
extremely difficult – even impossible. In order to properly address public health 
concerns, adequate and accurate data are essential. The manner in which a population 
obtains such information is typically through various health surveillance surveys and 
public records.  
While such information plays a vital role in gauging the health of society, it is 
important to remember its limitations. Much of the information derived from survey 
research regarding health behaviors is taken from cross-sectional data. While providing a 
picture, or ―slice‖ of information regarding the health of society at any particular 
moment, cross-sectional research cannot evaluate health trends over time. 
 The ability to track long-term trends in health behaviors and outcomes is 
important in adequately addressing concerns to public health. By observing long-term 
trends in health behaviors, a clearer picture of the nature of health issues and their impact 
can be assessed. Thacker and Berkelman (1988), in their commentary on the modern day 
conception of public health research, advise that ―one-time surveys or sporadic studies do 
not constitute surveillance‖ (164). Rather, for health surveillance research to assess 
population health adequately, it must be conducted in a manner that tracks health 
behaviors and/or outcomes over a period of time.  
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Thacker and Berkelman (1988) also note that surveillance is not enough if health 
data are not ―integrated into the conduct and evaluation of specific public health 
programs [...]‖ (164). Failing to connect the data that are collected through health 
surveillance surveys to potential or present remedial health policies limits the utility of 
public health research. Organizations that influence public health policies have a vested 
interest in tracking health related measures over time in order to evaluate the 
effectiveness of public health programs.  
Unfortunately, limitations sometimes arise with data that are used to track public 
health behaviors. A certain question may not be asked a certain year, or measures used to 
evaluate particular health issues may be ineffective. Certainly, great care and work is 
involved in creating the surveys which help monitor the public‘s health, but it is essential 
to detect limitations and devise strategies to overcome them. Many times those 
limitations are corrected in subsequent surveys; for instance, health measures may be 
revised or added. While this may resolve data limitations for future survey waves, it 
cannot address past limitations, and may also lead to inconsistent measurement between 
waves, creating difficulties in assessing long-term health trends. If public health 
surveillance is dependent on the continual monitoring of public health data, then the 
inability to utilize past survey waves limits the public health researcher in addressing 
important health-related issues.  
One such issue is the receipt of the seasonal influenza vaccine. Tracking seasonal 
influenza vaccinations through the BRFSS provides both state and national estimates in 
vaccination coverage. To reduce the disease burden of the seasonal flu in the United 
States., it is important to provide accurate seasonal estimates that detect at-risk groups, 
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possible disparities, and trends in vaccination coverage over time. In order to address 
such disparities this research will utilize the 2001 through 2010 BRFSS.  
 
The Behavioral Risk Factor Surveillance System (BRFSS) 
  The BRFSS is the longest ongoing telephone-based health surveillance survey in 
the world (CDC 2008). Throughout the year, surveys are administered in all 50 states (as 
well as the District of Columbia, Guam, the U.S Virgin Islands and Puerto Rico), 
gathering information on the health status of non-institutionalized adults over the age of 
18. The BRFSS is important because of its ability to ―identify emerging health problems, 
establish and track health objectives, and develop and evaluate public health policies and 
programs‖ (CDC 2008). Given that the BRFSS is administered by individual states and 
compiled by the CDC to be nationally representative, it is an important means of 
monitoring health on a national as well as state level. 
Beginning in 2001, the BRFSS included new measures of seasonal influenza 
vaccination behavior in its core questionnaire. Respondents were asked if they had 
received a seasonal flu vaccination in the past 12 months. Beginning in 2004, the BRFSS 
also asked if the respondent received a flu vaccination via nasal spray within the last 12 
months. While providing information regarding whether the respondent has recently 
received an influenza vaccine, the questions fail to specify during which flu season 
(which typically begin during late October or November of a given year and last through 
the summer of the next year; see CDC 2010b) the respondent reported his or her 
vaccination. Given the retrospective nature of the question and the fact that the BRFSS is 
administered throughout the year, the respondent could potentially report vaccination for 
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any of three possible influenza seasons. This limitation means that precise seasonal 
influenza vaccination estimates are not readily available. 
Not until the 2009 BRFSS was a follow-up question introduced, ascertaining the 
month and year of the respondents‘ most recent reported vaccination. The addition of this 
question allowed more accurate categorization of vaccinations into particular influenza 
seasons. Despite this improvement, the question does not identify the appropriate 
influenza season for respondents who did not receive a vaccination. Without a question 
asking if the respondent did or did not receive an influenza vaccination specifically 
during a particular flu season, it is not possible to estimate flu vaccination rates with 
exact precision. This issue in estimating seasonal flu vaccinations has been observed by 
other researchers (Lu, Euler, and Callahan. 2009; Linn et al. 2010; Setse et al. 2011), who 
have articulated various methods to account for the problem. This thesis presents a 
summary of those methods and utilizes an alternative method, first presented in Burger et 
al. (forthcoming), which allows for an accurate estimation of seasonal influenza 
vaccinations while retaining as many respondents as possible. After describing the 
method to be employed in this research, a brief comparison of these alternative 
approaches will be presented. 
 
Filtering Respondents by Month of Interview 
The 2009 and 2010 waves of the BRFSS were the first to report when the 
respondent received his or her seasonal influenza vaccination; data from these waves can 
be used to examine the distribution of reported influenza vaccinations for each flu season. 
As shown in Table 1, the 2009 BRFSS contains influenza vaccination data (either 
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through the traditional flu shot or nasal spray) for the 2007, 2008, and 2009 flu seasons. 
Similarly, in Table 2 it is observed that the 2010 BRFSS contains vaccination data for the 
2008, 2009, and 2010 flu seasons. Of those reporting a flu vaccination in the 2009 
BRFSS, most reported that their vaccination was for the 2008 flu season (77.3 percent). 
However, more than a fifth these respondents (22.7 percent) reported that their 
vaccination was for either the 2007 or 2009 flu seasons. Similarly, of those reporting 
vaccination in the 2010 BRFSS, a majority reported vaccination for the 2009 flu season 
(75.8 percent) and about a quarter (24.2 percent) reported vaccination for either the 2008 
or 2010 flu seasons. 
Given the seasonal nature of influenza epidemics and the regularity at which they 
occur, Burger et al. (forthcoming) propose that restricting respondents by month of 
interview will yield substantial improvements in the accuracy of estimates for seasonal 
vaccination rates. The logic used in restricting respondents by month of interview is 
illustrated through the following example. If a respondent is interviewed during January 
of any particular survey year, that individual cannot report receipt of a flu vaccination for 
the upcoming flu season since it would not begin until later, in the fall of that year. Given 
this fact and considering that vaccination for seasonal influenza typically begins in the 
last quarter of the year, respondents interviewed from January through September should 
be more likely to report the receipt of an influenza vaccination for the previous year‘s flu 
season.  
 Since the 2009 and 2010 BRFSS include information regarding the month and 
year of the respondent‘s last reported flu vaccination, these data are ideal for testing the 
method I have just outlined. As shown in Tables 1 and 2, significant gains in accuracy are 
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achieved by restricting respondents by interview months January through September. 
Restricting respondents in such a manner produced samples within the 2009 and 2010 
BRFSS where 97.9 percent and 97.4 percent of reported flu vaccinations correspond to 
the 2008 and 2009 influenza seasons, respectively. It is expected that the application of 
this method would produce similar gains in accuracy for previous years of the BRFSS, 
which would allow public health researchers to estimate past vaccination rates more 
accurately; this in turn facilitates better depictions of population trends in influenza 
vaccination (Burger et al. forthcoming). 
 
Previous Methods  
 While the method presented in Burger et al. (forthcoming) produces samples that 
are more representative of the prior year‘s flu season than is possible by utilizing the 
survey wave as a whole, other methods have also been proposed to address the issue of 
estimating seasonal influenza vaccinations within the BRFSS. Three of these approaches 
will be discussed in regard to their strengths and weaknesses and how they compare to 
the method that I advocate in this study. 
Linn et al 2010. In Linn et al. (2010) an analysis of disparities in seasonal 
influenza vaccinations is presented for the 2007 flu season using data from the 2008 
BRFSS. In their estimates, Linn et al. (2010) include all vaccination responses from the 
2008 BRFSS. While recognizing that this method is likely to include responses from flu 
seasons other than the season of interest, Linn et al. (2010) justify their methodology 
since ―when the sample was restricted to the first quarter of 2008 to avoid respondents 
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referencing different influenza seasons, the overall prevalence and disparities were 
essentially the same‖ (1339).  
However, just as mortality rates can differ depending on the flu season, so can 
vaccination uptake among the population. For example, increased media coverage of the 
flu and the importance of vaccination could increase vaccination rates (Ma et al. 2006). 
Also, problems in producing or administering influenza vaccines could result in lower 
seasonal estimates. For example, during the 2004 flu season a contamination problem led 
to the temporary shutdown of one of the two major pharmaceutical plants that produced 
influenza vaccines for the United States, causing a massive shortage in vaccinations 
(Schleicher 2004). This shortage resulted in a 50 percent reduction of vaccination 
supplies for the 2004 flu season (Zimmerman et al. 2006), which led to sharply lower 
rates of vaccination coverage. 
Therefore, the approach advocated by Linn et al. (2010) may be susceptible to 
inaccurate estimation of influenza vaccination rates. When applying the Linn et al. (2010) 
methodology to the 2009 and 2010 BRFSS (i.e., the entire survey wave is used to 
estimate the prior year‘s influenza season), some problems are observed. As shown in 
Table 1 and Table 2 nearly a quarter of the respondents during each survey year reported 
receipt of a vaccine for a flu season other than the one of interest. Including such a large 
proportion of respondents reporting vaccination for other flu seasons is likely to produce 
inaccuracies in subsequent analyses. 
 Lu et al. 2009. Lu et al. (2009) estimate seasonal influenza vaccination rates for 
individuals 18 through 64 with asthma during the 2006 influenza season using data from 
the 2007 BRFSS. To produce their estimates, Lu et al. (2009) use respondents 
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interviewed from February through August of 2007. This method recognizes that many 
respondents within the BRFSS report influenza vaccinations for flu seasons other than the 
one of interest, and that limiting respondents by time of interview improves the accuracy 
of seasonal vaccination estimates. While this does indeed improve accuracy, the choice of 
survey months is somewhat restricted, limiting sample size and potentially compromising 
statistical power. Limiting respondents by interview months February through August of 
the 2009 and 2010 BRFSS retains only 77.1 percent and 73.1 percent of the original 
respondents who reported a vaccination during the 2008 and 2009 influenza seasons, 
respectively.   
 Adopting the technique introduced in Burger et al. (forthcoming) (i.e., including 
BRFSS respondents interviewed from January through September) improves retention to 
94.6 percent and 91.7 percent of the respondents who received a vaccine for the 2008 and 
2009 flu seasons. This maximizes the number of respondents included in each wave of 
the BRFSS, ensuring that a representative sample is obtained and that statistical power is 
optimized. 
 Setse et al. 2011. In Setse et al. (2011) seasonal vaccination estimates are 
provided for the United States for the 2000 through 2009 influenza seasons. Using the 
2001 through 2010 survey waves of the BRFSS, Setse et al. (2011) examine racial/ethnic 
disparities in influenza vaccination within the United States. Following a similar 
approach as found in Lu et al. (2009), Setse et al. (2011) instead limit respondents in each 
wave of the BRFSS by interview months March through August to estimate seasonal. 
When applying the method as proposed in Setse et al. (2011) to the 2009 and 2010 
BRFSS, samples are produced where 98.5 percent and 98.2 percent of those interviewed 
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represent the 2008 and 2009 influenza seasons. While miniscule gains in accuracy can be 
achieved by restricting the sample to these interview months, they are overshadowed by 
the fact that this method excludes more than a third of the original respondents who 
reported a flu vaccination for either the 2008 or the 2009 influenza seasons. 
 
Comparison using the National Health Interview Survey (NHIS) 
 In order to ensure that the benefits of using interview months January through 
September are not anomalous to the 2009 and 2010 waves of the BRFSS, similar 
analyses are performed using data from the 2005 through 2010 National Health Interview 
Survey (NHIS) sample adult file. Sponsored by the CDC, the NHIS has been conducted 
annually since 1957. Similar to the BRFSS, the NHIS provides health information on 
non-institutionalized adults in the United States. The NHIS is considered the ―principle 
source of information‖ for that population (CDC 2011a). However, the NHIS differs 
significantly from the BRFSS in that data are collected using a completely different 
collection procedure. While the BRFSS provides data acquired through telephone based 
surveys, the NHIS data are gathered via face-to-face interviews.  
Since the logic which allows gains in accuracy to be made within the BRFSS can 
also apply to the NHIS (i.e., that individuals interviewed prior to October of the survey 
year generally cannot report a flu vaccination for the upcoming flu season), it should be 
possible to improve the accuracy of NHIS estimates of seasonal influenza vaccination 
rates, as it was for the BRFSS. It should be noted that instead of month of interview (as in 
the BRFSS) the NHIS records when the respondent was interviewed into four interview 
quarters (January through March, April through June, July through September, and 
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TABLE 1. Comparison of Methods of Estimating Seasonal Influenza Vaccination   
Within the 2009 Behavioral Risk Factor Surveillance System (BRFSS). 
 
Entire Sample 
Interview Month:  
January ´09 – January ´10 
Linn et al. 2010 
Restricting Vaccinations  
by Interview Month: 
January ´09 – September ´09 
Burger et al.(forthcoming) 
Restricting Vaccinations  
by Interview Month: 
October ´09 – January ´10 
Lu et al. 2009 
Restricting vaccination by 
Interview Month: 
March ´09 – August ´10 
Setse et al. 2011 
Flu 
Season 
n % 
Flu 
Season 
n % 
Flu 
Season 
n % 
Flu 
Season 
n % 
2007a 2,341 1.24% 2007a 2,341 1.64% 2007a 1,909 1.66% 2007a 1,448 1.50% 
2008b 146,263 77.32% 2008b 138,337 97.13% 2008b 112,720 98.30% 2008b 95,162 98.46% 
2009c 40,568 21.45% 2009c 1,743 1.22% 2009c 45 0.04% 2009c 44 0.05% 
Total 189,172 100% Total 142,421 100% Total 114,674 100% Total 96,654 100% 
a. Received flu vaccination from 01/07–08/07.  
b. Received flu vaccination from 09/07–08/08.  
c. Received flu vaccination from 09/08–12/09.  
 
TABLE 2. Comparison of Methods of Estimating Seasonal Influenza Vaccination   
Within the 2010 Behavioral Risk Factor Surveillance System (BRFSS). 
 
Entire Sample 
Interview Month:  
January ´09 – January ´10 
Linn et al. 2010 
Restricting Vaccinations  
by Interview Month: 
January ´09 – September ´09 
Burger et al. (forthcoming) 
Restricting Vaccinations  
by Interview Month: 
October ´09 – January ´10 
Lu et al. 2009 
Restricting vaccination by 
Interview Month: 
March ´09 – August ´10 
Setse et al. 2011 
Flu 
Season 
n % 
Flu 
Season 
n % 
Flu 
Season 
n % 
Flu 
Season 
n % 
2008a 2,752 1.36% 2007a 2,752 1.91% 2007a 2,276 2.00% 2007a 1,763 1.81% 
2009b 152,988 75.75% 2008b 140,246 97.42% 2008b 111,791 97.99% 2008b 95,427 98.17% 
2010c 46,212 22.88% 2009c 965 0.67% 2009c 17 0.01% 2009c 16 0.02% 
Total 201,952 100% Total 143,963 100% Total 114,084 100% Total 97,206 100% 
a. Received flu vaccination from 01/08–08/08.  
b. Received flu vaccination from 09/08–08/09.  
c. Received flu vaccination from 09/09–12/10.  
 
33 
 
October through December). This allows a convenient comparison of the effectiveness of 
restricting respondents by interview months January through September in the BRFSS to 
the first three quarters (January through September) of the NHIS. Tables 3 through 8 
shows during which flu season the respondent reported the influenza vaccination (either 
through the traditional flu shot or nasal spray) for the 2005 through 2010 waves of the 
NHIS. First, all reported vaccinations are placed in their respective flu seasons, and then 
vaccinations are shown while restricting respondents to the first three quarters of the 
survey wave. 
For each wave of the NHIS from 2005 to 2010, gains in the accuracy of estimates 
for seasonal flu vaccination rates can be achieved by limiting respondents to the first 
three quarters of the survey wave. Compared to using the entire survey wave, restricting 
respondents in this manner improved my ability to isolate a specific flu season among 
respondents who received an influenza vaccine; specifically, the percentage of 
respondents who received their flu shot in the previous flu season increased from 77.4 
percent to 97.4 percent, on average. This improvement in the ability of the NHIS to 
represent a specific flu season is accomplished while still retaining, on average, 91.3 
percent of all respondents who reported receiving a flu vaccine in the year prior to the 
NHIS interview. The improved ability to isolate vaccinations to specific flu seasons 
means that providing seasonal influenza vaccination estimates or performing seasonal 
analyses can be performed with greater confidence. 
The approach advocated in Burger et al. (forthcoming) of filtering respondents by 
interview months January through September works equally well for two 
methodologically different surveys, which is indicative of the general applicability and 
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usefulness of this method. Even in flu seasons where dramatic disruptions occurred in the 
distribution of flu vaccinations throughout society, such as during the shortage 
experienced during the 2004 influenza season, restricting respondents by interview 
months January through September produces samples which allow for a more accurate 
estimation of seasonal influenza vaccinations. 
 
 
TABLE 3. Reported Seasonal Influenza Vaccination by Flu Season, 
 2005 National Health Interview Survey (NHIS) 
Entire Sample 
Interview Quarter:  
Q1-Q4 
Restricting Vaccination 
by Interview Quarter: 
Q1-Q3 
Restricting Vaccination 
by Interview Quarter:  
Q4 
Flu 
Season n % 
Flu 
Season n % 
Flu 
Season n % 
2003a 96 1.39% 2004a 96 1.91% 2004a 0 0.00% 
2004b 5,516 79.78% 2005b 4,925 97.99% 2005b 591 31.30% 
2005c 1,302 18.84% 2006c 15 0.10% 2006c 1,297 68.70% 
Total 6,914 100% Total 5,026 100% Total 1,888 100% 
a. Received flu vaccination from 01/03-08/03. 
b. Received flu vaccination from 09/03-08/04. 
c. Received flu vaccination from 09/04-12/04. 
 
TABLE 4. Reported Seasonal Influenza Vaccination by Flu Season, 
 2006 National Health Interview Survey (NHIS) 
Entire Sample 
Interview Quarter:  
Q1-Q4 
Restricting Vaccination 
by Interview Quarter: 
Q1-Q3 
Restricting Vaccination 
by Interview Quarter:  
Q4 
Flu 
Season n % 
Flu 
Season n % 
Flu 
Season n % 
2004a 95 1.43% 2004a 95 2.03% 2004a 0 0.00% 
2005b 5,102 76.64% 2005b 4,572 97.75% 2005b 530 26.77% 
2006c 1,460 21.93% 2006c 10 0.21% 2006c 1,450 73.23% 
Total 6,657 100% Total 4,677 100% Total 1,980 100% 
a. Received flu vaccination from 01/04-08/04. 
b. Received flu vaccination from 09/04-08/05. 
c. Received flu vaccination from 09/05-12/05. 
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TABLE 5. Reported Seasonal Influenza Vaccination by Flu Season, 
 2007 National Health Interview Survey (NHIS) 
Entire Sample 
Interview Quarter:  
Q1-Q4 
Restricting Vaccination 
by Interview Quarter: 
Q1-Q3 
Restricting Vaccination 
by Interview Quarter:  
Q4 
Flu 
Season n % 
Flu 
Season n % 
Flu 
Season n % 
2005a 68 0.97% 2005a 68 1.37% 2005a 0 0.00% 
2006b 5,361 76.44% 2006b 4,887 98.45% 2006b 474 23.13% 
2007c 1,584 22.59% 2007c 9 0.18% 2007c 1,575 76.87% 
Total 7,013 100% Total 4,964 100% Total 2,049 100% 
a. Received flu vaccination from 01/06-08/06. 
b. Received flu vaccination from 09/06-08/07. 
c. Received flu vaccination from 09/07-12/07. 
 
TABLE 6. Reported Seasonal Influenza Vaccination by Flu Season, 
 2008 National Health Interview Survey (NHIS) 
Entire Sample 
Interview Quarter:  
Q1-Q4 
Restricting Vaccination 
by Interview Quarter: 
Q1-Q3 
Restricting Vaccination 
by Interview Quarter:  
Q4 
Flu 
Season n % 
Flu 
Season n % 
Flu 
Season n % 
2006a 101 1.40% 2006a 101 1.64% 2006a 0 0.00% 
2007b 6,326 87.46% 2007b 6,032 97.99% 2007b 294 27.30% 
2008c 806 11.14% 2008c 23 0.37% 2008c 783 72.70% 
Total 7,233 100% Total 6,156 100% Total 1,077 100% 
a. Received flu vaccination from 01/07-08/07. 
b. Received flu vaccination from 09/07-08/08. 
c. Received flu vaccination from 09/08-12/08. 
 
TABLE 7. Reported Seasonal Influenza Vaccination by Flu Season, 
 2009 National Health Interview Survey (NHIS) 
Entire Sample 
Interview Quarter:  
Q1-Q4 
Restricting Vaccination 
by Interview Quarter: 
Q1-Q3 
Restricting Vaccination 
by Interview Quarter:  
Q4 
Flu 
Season n % 
Flu 
Season n % 
Flu 
Season n % 
2007a 102 1.08% 2007a 102 1.73% 2007a 6 0.20% 
2008b 6,147 64.87% 2008b 5,586 94.77% 2008b 561 15.64% 
2009c 3,227 34.05% 2009c 206 3.50% 2009c 3,021 84.20% 
Total 9,476 100% Total 5,894 100% Total 3,588 100% 
a. Received flu vaccination from 01/08-08/08. 
b. Received flu vaccination from 09/08-08/09. 
c. Received flu vaccination from 09/09-12/09. 
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 In fact, creating samples by restricting respondents by month of interview, or 
quarter of interview, seems to be a viable option in improving the usefulness of the 
BRFSS and the NHIS in accurately estimating seasonal vaccination rates. Utilizing this 
approach will produce more accurate estimates of long-term trends in seasonal influenza 
vaccinations in the United States, which will result in better evaluations of health policies 
that affect vaccination coverage. 
While not perfect, limiting respondents to those interviewed from January through 
September retains more BRFSS respondents than alternative approaches, thus including 
as much data as possible for analysis. Due to smaller samples, retention of respondents is 
especially important when producing state-based estimates using BRFSS data. Given 
these advantages, all analyses in this study will consider only those respondents 
interviewed from January through September, which strikes the best balance between 
statistical power and the accuracy of flu season estimates. Those interviewed in October 
through December of each wave of the BRFSS will be excluded from subsequent 
analyses. 
 
TABLE 8. Reported Seasonal Influenza Vaccination by Flu Season, 
 2010 National Health Interview Survey (NHIS) 
Entire Sample 
Interview Quarter:  
Q1-Q4 
Restricting Vaccination 
by Interview Quarter: 
Q1-Q3 
Restricting Vaccination 
by Interview Quarter:  
Q4 
Flu 
Season n % 
Flu 
Season n % 
Flu 
Season n % 
2008a 125 1.37% 2008a 125 1.81% 2008a 0 0.00% 
2009b 7,252 79.38% 2009b 6,617 95.97% 2009b 635 28.18% 
2010c 1,759 19.25% 2010c 153 2.22% 2010c 1618 71.82% 
Total 9,136 100% Total 6,895 100% Total 2,253 100% 
a. Received flu vaccination from 01/09-08/09. 
b. Received flu vaccination from 09/09-08/010. 
c. Received flu vaccination from 09/10-12/10. 
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Measures 
Dependent Variable. In the BRFSS, influenza vaccination is measured by asking 
respondents if they received an influenza vaccine in the last 12 months. The informants 
were then coded as having responded ―Yes,‖ ―No,‖ ―Don‘t Know,‖ or ―Refused.‖ 
Beginning in 2004, the BRFSS introduced an additional question asking if the respondent 
had received an influenza vaccination through a nasal spray. Given the small number of 
respondents reporting a nasal flu vaccine and the possibility of complicating the analysis 
by double counting vaccination, only respondents reporting an influenza vaccination 
administered through a shot will be considered, consistent with the approach advocated in 
Lu et al. (2008). Respondents who responded ―Don‘t Know‖ or ―Refused‖ are excluded 
from analyses. 
It should be noted that the analyses presented in this study are solely limited to the 
seasonal influenza vaccination and do not include information referring to the 2009 
H1N1 pandemic influenza vaccination which was administered separately.  
Independent Variables. In the BRFSS, race is measured separately from Hispanic 
ethnicity. Since the principal racial and ethnic groups of interest in this investigation are 
non-Hispanic whites and Hispanics, these two mutually exclusive groups are created by 
combining the race and Hispanic ethnicity variables. For reasons of simplicity, the term 
white will be used interchangeably with non-Hispanic white. Individuals who refused to 
report their race/ethnicity or did not know were excluded from analysis. Analyses are 
limited to white and Hispanic respondents from the fifty United States as well as the 
District of Columbia. Respondents from Puerto Rico, Guam, and the U.S. Virgin Islands 
are not included. 
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Key Covariates. Other independent variables of interest include age, sex, level of 
education, household income, period of observation, and healthcare coverage. Age is 
collapsed into six categories including: 18 through 24, 25 through 34, 35 through 44, 45 
through 54, 55 through 64, and ≥65. Educational attainment is recoded into five 
categories including: ―Less than High School,‖ ―High School Graduate,‖ ―Some College 
or Technical School,‖ and ―College Graduate.‖ To create the ―Less than High School‖ 
category the following responses are combined: ―Never Attended School or Only 
Kindergarten,‖ ―Elementary School (grades 1 through 8),‖ and ―Some High School 
(grades 9 through 11).‖ Household income is collapsed into seven different categories, 
<$14,999; $15,000 through $24,999; $25,000 through $34,999; $35,000 through 
$49,000; $50,000 through $74,999 and <$75,000. 
Whether or not the respondent had some form of healthcare coverage was 
assessed through the question, ―Do you have any kind of health care coverage, including 
health insurance, prepaid plans such as HMOs, or government plans such as Medicare?‖ 
to which the respondent replied ―Yes,‖ ―No,‖ ―Don‘t Know,‖ or ―Refused.‖ Individuals 
replying ―Don‘t Know‖ or ―Refused‖ to the age, sex, level of education, household 
income, or presence of healthcare coverage were excluded. 
 
Analyses 
 All statistical analyses were performed using PASW 18 (formerly known as 
SPSS) and Microsoft Excel 2007. Given the complex design of the BRFSS sample, the 
Complex Sample Module was used in conjunction with PASW 18 to provide appropriate 
point and variance estimates. Overall trends in influenza vaccination were observed for 
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white and Hispanic males and females during the 2000 through 2009 influenza seasons. 
Linear regression trend lines were also added to summarize trends in seasonal vaccination 
during the 2000 through 2009 seasons. 
In addition, vaccination rates were estimated for whites and Hispanics by specific 
sociodemographic characteristics for the 2000 through 2009 influenza seasons. 
Difference of proportion tests were used to determine if statistically significant 
differences in seasonal vaccination exist between whites and Hispanics within these 
sociodemographic subgroups.  
Finally, a series of binary logistic regression models were estimated for males and 
females to test the propositions set forth by FCT – namely that whites secure health 
benefits (influenza vaccinations) through the use of flexible resources. When flexible 
resources such as education and health care coverage are held constant, the magnitude of 
racial/ethnic disparities is expected to lessen. These models should provide insight into 
mechanisms underlying racial and ethnic disparities while also providing a critical 
assessment of the fundamental cause explanation for disparities in seasonal influenza 
vaccinations. Three models are estimated that control for key covariates: Model 1 
includes race/ethnicity, age, and period of observation, showing the effect of Hispanic 
ethnicity on the odds of reporting an influenza vaccination, net of these potential 
confounders. Model 2 includes the previously used variables while introducing healthcare 
coverage. Model 3 controls for the previously mentioned variables while adding 
household income and the respondent‘s highest level of education.   
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CHAPTER V 
RESULTS 
 
Seasonal Trends in Influenza Vaccination 
 In Figures 2 and 3, estimated seasonal vaccination rates are presented for white 
and Hispanic males and females. As observed in previous research, substantial disparities 
in the receipt of the seasonal influenza vaccination are observed by race/ethnicity and 
sex. Among all four groups examined in this study – Hispanic females, Hispanic males, 
non-Hispanic white females and non-Hispanic white males – increases in vaccination 
rates were observed. However, large differences between whites and Hispanics were 
detected among both males and females. For white males, the rate of seasonal influenza 
vaccination increased from 31.5 percent (95 percent CI, 30.8 through 32.1) during the 
2000 influenza season to 39.5 percent (95 percent CI, 39.0 through 40.1) during the 2009 
influenza season, resulting in a relative increase of 25.4 percent over the 10 flu seasons. 
Hispanic males experienced a smaller relative increase of around 12.5 percent over the 
same time period —from 22.3 percent (95 percent CI, 20.3 through 24.4) during the 2000 
influenza season to 25.1 percent (95 percent CI, 23.3 through 27.0) during the 2009 
influenza season.  
 White females experienced even greater gains in relative terms (34.9 percent), 
with vaccination rates rising from 34.4 percent (95 percent CI, 33.9 through 35.0) during 
the 2000 influenza season to 46.4 percent (95 percent CI, 46.0 through 46.9) during the 
2009 influenza season. Hispanic females experienced a relative increase of 29.8 percent 
during the period of observation, increasing from 23.5 percent (95 percent CI, 21.6  
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FIGURE 2. Estimated Trends in Influenza Vaccination Rates for 
White and Hispanic Males Age ≥18 in the United States,
2000-2009 Influenza Seasons.
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FIGURE 3. Estimated Trends in Influenza Vaccination Rates for 
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through 25.5) during the 2000 influenza season to 30.5 percent (95 percent CI, 29.2 
through 31.9) during the 2009 influenza season. 
 Although Hispanics experienced upward trends in seasonal influenza vaccinations 
during these ten flu seasons, they increased at a somewhat slower pace than their white 
counterparts. It is disconcerting to note that while influenza vaccinations are rising for 
both groups overall, the gap between whites and Hispanics widened during the time 
period. The evidence shows that the gap in seasonal vaccinations between whites and 
Hispanics during the 2009 influenza season is actually greater than what was present 
during the 2000 influenza season.  
However, it is important to remember the difference age can play in receipt of an 
influenza vaccination, with the elderly often experiencing higher rates of vaccination 
(Simonson et al. 2005). Given this fact, the dramatic differences between whites and 
Hispanics as observed in Figures 2 and 3 could be a result of whites, on average, being 
older than Hispanics. Considering that the Hispanic demographic is considerably younger 
than non-Hispanic whites it is important to examine seasonal influenza vaccinations 
according to specific age categories as well as by other sociodemographic characteristics.  
 Tables 9 and 10 compare vaccination rates for non-Hispanic whites and Hispanics 
over ten consecutive flu seasons, by various sociodemographic characteristics. Seasonal 
influenza vaccination rates are presented for whites in Table 9, and vaccination rates are 
presented for Hispanics in Table 10. For nearly all sociodemographic subgroups, the 
proportions of Hispanics vaccinated were statistically lower than their white counterparts.  
In nearly every age category across the ten seasons of observation, Hispanics 
report significantly lower rates of influenza vaccination than whites. However, it is 
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interesting to note that in seven of the ten seasons, Hispanics in the youngest age group 
(18 through 24) experienced vaccination rates that were not significantly different than 
whites of similar age. Also of note is that during the 2004 influenza season (in which 
there were large shortages of influenza vaccination supplies), Hispanics 25 through 34, 
35 through 44, and 55 through 64 experienced vaccination rates on par with their white 
counterparts. 
One of the most dramatic differences between whites and Hispanics in influenza 
vaccination coverage was observed among the oldest respondents, those ages ≥65. Over 
the ten-season period, 56.5 percent of Hispanics ≥65 received a flu vaccine, compared to 
71.5 percent of non-Hispanic whites in the same age group.  
When examining flu vaccination by sex, white females consistently exhibited 
higher vaccination rates than white males over the ten-season period. This finding 
confirms prior research showing that females are more likely than males to receive 
preventive health care services (Pinkhasov et al. 2010). In contrast, while Hispanic 
females also tend to receive the flu vaccination at higher rates than Hispanic males, they 
do not seem to experience the same gender-based advantages as white females. For 
example, during the 2004 and 2005 flu seasons, which were seasons in which vaccination 
materials were in short supply, Hispanic males actually tended to have slightly higher 
vaccination rates than Hispanic females.  
 In every income category, vaccination rates were higher among whites than 
Hispanics. During most flu seasons, with the exception of the 2000 and 2004 influenza 
seasons, income seems to play a positive role in influencing vaccinations. Similarly, rates 
of influenza vaccination tend to increase with level of education. 
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For both whites and Hispanics, substantial absolute differences in vaccination 
rates exist between those with or without some form of healthcare coverage. Vaccination 
rates were often more than 20 percent higher among insured whites than uninsured 
whites. While differences are also observed between insured and uninsured Hispanics, 
they are less dramatic. On average, insured Hispanics experience absolute vaccination 
rates 12.7 percent higher than uninsured Hispanics. Between insured whites and 
Hispanics, statistically significant differences were found in every flu season (p <.001). 
However, while statistically significant differences between uninsured whites and 
Hispanics were obtained for six of the ten flu seasons; those absolute differences are 
often small, averaging about 2 to 3 percent.  
While Tables 9 and 10 provide ample evidence of substantial disparities in 
reported flu vaccination between whites and Hispanics, it does little to provide insight as 
to the effect of social conditions (as described in FCT) on receiving the vaccine. In 
Tables 11 and 12, results of logistic regression models are presented estimating the effect 
of race/ethnicity and SES on the odds of receiving a flu vaccination. Table 11 presents a 
series of logistic regression models for white and Hispanic males, and Table 12 presents 
the same series of logistic regression models for white and Hispanic females.  
Odds of Reporting Influenza Vaccination: Males 
As shown in Model 1 of Table 11, Hispanic males, in absolute terms, experience 
25.3 percent (p < .001) lower odds of reporting a flu vaccination than white males when 
controlling for age and period of observation. The model exhibits the known positive 
association between age and receipt of the seasonal flu vaccination.  
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TABLE 9.   Influenza Vaccination Coverage for Whites Age ≥18 in the United States, 2000-2009 Flu Seasons. 
Characteristics 
 
2000 Flu Season 
 
 
2001 Flu Season  2002 Flu Season  2003 Flu Season  2004 Flu Season 
 n % C.I.  n % C.I.  n % C.I.  n % C.I.  n % C.I. 
Age                    
   18-24 9,060 18.7 17.5-20.0  9,613 18.6 17.4-20.0  9,363 20.1 18.8-21.4  9,394 21.3 19.9-22.8  9,136 15.3 14.1-16.6 
   25-34 18,726 16.1 15.3-16.9  21,354 15.0 14.2-15.8  21,323 18.1 17.3-19.0  22,883 23.0 22.1-24.0  24,230 13.5 12.7-14.2 
   35-44 24,657 18.6 17.9-19.4  28,742 19.5 18.8-20.3  29,681 21.1 20.3-21.8  31,573 26.5 25.6-27.3  35,772 13.3 12.7-13.9 
   45-54 23,435 27.0 26.1-28.0  29,428 28.5 27.6-29.3  32,675 30.3 29.4-31.1  36,401 36.7 35.8-37.6  43,684 17.5 16.9-18.2 
   55-64 15,917 41.5 40.3-42.8  21,726 42.6 41.6-43.6  25,975 45.6 44.6-46.7  30,567 52.3 51.3-53.3  39,644 29.7 28.9-30.4 
   ≥ 65 24,336 68.7 67.7-69.6  32,061 70.3 69.5-71.2  35,773 73.0 72.2-73.8  42,890 75.7 75.0-76.5  55,234 66.3 65.6-67.0 
                    
Sex                    
  Male 47,743 31.5 30.8-32.1  57,868 31.3 30.7-31.9  62,203 33.9 33.3-34.5  68,145 37.6 37.0-38.3  80,526 24.6 24.1-25.2 
  Female 69,419 34.4 33.9-35.0  86,005 34.9 34.4-35.4  93,636 37.8 36.2-38.3  106,409 43.3 42.8-43.8  128,512 29.3 28.9-29.7 
                    
Household Income                    
  < $14,999 10,208 36.2 34.6-38.0  12,321 36.7 35.1-38.2  13,444 39.4 37.9-40.9  15,559 41.3 39.8-42.9  18,154 32.1 30.8-33.5 
  $15,000-$24,999 17,317 37.7 36.5-39.0  21,186 36.8 35.8-37.9  22,950 39.1 38.0-40.2  25,617 41.9 40.8-43.1  30,015 33.0 32.0-34.0 
  $25,000-$34,999 15,596 32.7 31.6-33.9  18,715 34.5 33.4-35.6  19,208 37.5 36.3-38.8  21,162 40.4 39.2-41.6  24,497 30.9 29.9-31.9 
  $35,000-$49,999 19,441 30.1 29.1-31.1  23,833 30.2 29.3-31.1  25,469 33.3 32.3-34.3  27,553 38.8 37.8-39.8  31,977 26.0 25.1-26.8 
  $50,000-$74,999 18,203 27.8 26.8-28.8  22,895 28.6 27.7-29.5  24,823 32.5 31.5-33.4  27,729 37.3 36.3-38.3  33,410 22.5 21.7-23.2 
  ≥ $75,000 19,627 30.1 29.1-31.1  25,291 30.6 29.7-31.5  29,752 32.6 31.7-33.4  34,024 39.1 38.2-40.0  43,290 21.6 21.0-22.3 
                    
Education                    
  < High School  11,000 36.6 35.2-38.1  12,776 34.9 33.6-36.2  12,833 38.2 36.8-39.6  14,017 40.6 39.1-42.2  16,781 31.0 29.8-32.3 
  HS or GED 36,884 32.6 31.8-33.3  45,780 32.8 32.2-33.5  47,293 35.3 34.6-36.1  53,363 38.5 36.7-39.3  64,316 27.6 27.0-28.3 
  1-3 Years College 32,171 31.2 30.4-32.0  38,986 31.7 31.0-32.5  43,155 34.2 33.4-35.0  47,291 39.2 38.4-40.1  56,005 25.1 24.5-25.8 
  ≥ 4 Years College 36,834 34.0 33.3-34.8  46,091 34.3 33.6-35.0  52,289 37.2 36.5-37.9  59,566 43.4 42.7-44.1  71,562 27.2 26.7-27.8 
                    
Healthcare  Coverage                    
  Yes 104,915 35.2 34.7-35.6  128,418 35.6 35.2-36.0  139,098 38.5 38.0-38.9  155,782 43.4 42.9-43.8  187,781 29.0 28.7-29.4 
  No 11,993 14.0 13.0-15.1  15,121 14.0 13.1-15.0  16,392 15.5 14.5-16.5  18,376 19.1 18.1-20.2  20,800 11.5 10.7-12.3 
                    
n= unweighted sample size. 
CI = confidence interval. 
% and CI are calculated from weighted values. 
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TABLE 9 continued.   Influenza Vaccination Coverage for Whites Age ≥18 in the United States, 2000-2009 Flu Seasons 
Characteristics 
 
2005 Flu Season 
 
 
2006 Flu Season  2007 Flu Season  2008 Flu Season  2009 Flu Season 
 n % C.I.  n % C.I.  n % C.I.  n % C.I.  n % C.I. 
Age                    
   18-24 7,334 17.2 15.4-19.1  7,451 21.1 19.6-22.6  6,444 21.5 19.9-23.2  6,140 23.5 21.8-25.3  5,589 24.6 22.9-26.3 
   25-34 21,107 20.0 19.1-21.0  22,638 24.9 24.0-24.9  19,786 24.6 23.6-25.6  18,702 27.1 26.1-28.2  16,745 31.5 30.4-32.6 
   35-44 33,304 21.3 20.4-22.1  37,074 27.2 26.5-28.0  33,601 27.4 26.7-28.2  32,412 29.8 29.0-30.7  30,078 33.1 32.2-34.0 
   45-54 42,431 28.0 27.2-28.9  51,049 33.6 32.9-34.3  48,441 33.5 32.8-34.2  49,935 36.1 35.4-36.8  47,440 36.7 36.0-37.4 
   55-64 40,991 43.4 42.5-44.3  53,132 48.7 47.9-49.4  52,482 49.5 48.8-50.2  57,124 50.7 50.0-51.4  58,670 50.3 49.6-50.9 
   ≥65 56,808 71.6 70.9-72.3  76,185 73.9 73.4-74.4  76,030 73.5 73.0-74.0  84,070 72.6 72.1-73.1  89,842 69.2 68.7-69.7 
                    
Sex                    
  Male 78,134 31.7 31.1-32.4  94,300 36.8 36.3-37.4  90,391 36.9 36.4-37.5  95,769 38.6 38.0-39.2  95,608 39.5 39.0-40.1 
  Female 125,386 37.7 37.1-38.2  154,999 42.8 42.4-43.3  148,041 42.8 42.3-43.3  154,257 44.8 43.3-45.3  154,526 46.4 46.0-46.9 
                    
Household Income                    
  ≤$14,999 16,903 35.8 34.2-37.4  19,130 40.2 38.8-41.7  18,305 38.6 37.2-40.1  19,214 38.1 36.6-39.6  20,425 35.5 34.2-36.9 
  $15,000-$24,999 27,355 38.5 37.3-39.8  33,649 42.5 41.5-43.5  31,841 42.1 41.0-43.1  34,918 41.2 40.1-42.3  35,700 40.7 39.7-41.7 
  $25,000-$34,999 22,456 36.7 35.5-38.0  26,796 40.9 39.8-42.0  24,976 42.3 41.1-43.5  26,019 42.7 41.6-43.9  25,691 43.0 41.9-44.1 
  $35,000-$49,999 30,263 33.7 32.7-34.8  36,540 38.5 37.6-39.5  33,584 39.2 38.2-40.2  35,244 40.7 39.7-41.7  34,269 42.6 41.6-43.6 
  $50,000-$74,999 32,520 31.7 30.7-32.7  39,408 37.5 36.7-38.4  38,219 37.7 36.9-38.6  38,526 40.4 39.5-41.3  36,588 42.2 41.3-43.1 
   ≥$75,000 46,806 32.4 31.5-33.3  60,876 38.9 38.2-39.6  61,812 39.0 38.3-39.7  64,663 42.2 41.5-42.9  63,468 45.4 44.7-46.1 
                    
Education                    
  < High School  15,473 35.5 33.9-37.1  18,947 38.4 37.1-39.7  16,888 37.3 35.8-38.8  16,971 38.2 36.7-39.7  17,248 35.4 34.0-36.8 
  HS or GED 61,514 33.9 33.1-34.8  76,464 38.2 37.5-38.8  71,854 37.5 36.8-38.2  74,793 39.3 38.6-40.0  74,769 39.1 38.4-39.7 
  1-3 Years College 55,090 32.7 31.9-33.5  66,800 37.7 37.0-38.4  64,639 38.5 37.8-39.2  68,583 39.7 39.0-40.4  68,034 41.1 40.4-41.8 
  ≥ 4 Years College 71,121 37.0 36.3-37.7  86,566 43.3 42.7-43.9  84,714 43.6 43.0-44.2  89,324 45.9 45.2-46.5  89,711 48.5 47.9-49.1 
                    
Healthcare Coverage                    
  Yes 184,067 37.5 37.0-37.9  225,993 42.7 42.4-43.1  218,417 42.8 42.4-43.2  228,866 44.9 44.5-45.3  228,935 46.3 45.9-46.7 
  No 19,021 13.8 12.8-14.8  22,757 16.9 16.0-17.8  19,553 16.2 15.3-17.2  20,680 16.9 16.0-17.9  20,677 17.5 16.6-18.5 
                    
n= unweighted sample size. 
CI = confidence interval. 
% and CI are calculated from weighted values. 
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TABLE 10. Influenza Vaccination Coverage for Hispanics Age ≥18 in the United States, 2000-2009 Flu Seasons 
Characteristics 2000 Flu Season  2001 Flu Season  2002 Flu Season  2003 Flu Season  2004 Flu Season 
 n % C.I.  n % C.I.  n % C.I.  n % C.I.  n % C.I. 
Age                    
   18-24 1,738 19.7 16.8-23.0  1,795 15.3*** 13.0-17.9  1,749 20.4 17.4-23.9  1,913 18.5** 15.7-21.7  1,999 17.9** 14.8-21.5 
   25-34 3,068 17.6* 15.5-19.9  3,179 15.3 13.0-17.8  3,515 14.4*** 12.6-16.5  3,976 18.4*** 16.2-20.8  4,441 13.8 11.9-15.8 
   35-44 2,964 17.1* 14.3-20.2  2,961 16.2*** 13.9-18.8  3,384 19.4* 17.0-22.1  3,895 19.5*** 17.4-21.7  4,441 12.9 11.2-14.8 
   45-54 2,128 19.0*** 16.1-22.3  2,191 21.0*** 17.9-24.5  2,394 21.5*** 18.4-25.0  2,885 25.4*** 22.2-29.0  4,256 15.5*** 13.2-18.1 
   55-64 1,374 35.2*** 29.7-41.1  1,462 32.3*** 27.4-37.5  1,665 33.4*** 28.8-38.4  1,937 35.1*** 30.6-39.9  3,250 30.2 26.1-34.7 
   ≥65 1,599 54.6*** 49.5-59.7  1,713 55.7*** 49.8-61.5  1,868 61.5*** 56.3-66.5  2,287 63.0*** 58.1-67.6  2,238 52.1*** 47.1-57.0 
                    
Sex                    
  Male 5,019 22.3*** 20.3-24.4  5,264 20.6*** 18.7-22.6  5,583 21.7*** 19.7-23.7  6,476 24.2*** 22.3-26.3  6,959 19.7*** 17.9-21.6 
  Female 7,903 23.5*** 21.6-25.5  8,087 21.7*** 20.0-23.6  9,057 25.3*** 23.5-27.1  10,471 25.0*** 23.4-26.7  11,702 18.8*** 17.4-20.2 
                    
Household Income                    
  ≤$14,999 3,371 25.3*** 22.3-28.6  3,166 20.3*** 17.7-23.3  3,504 22.4*** 19.7-25.2  4,033 22.7*** 20.1-25.5  3,843 20.5*** 17.8-23.5 
  $15,000-$24,999 3,004 22.8*** 20.2-25.5  3,219 19.5*** 17.1-22.3  3,642 22.4*** 19.9-25.2  4,138 23.7*** 21.3-26.3  4,812 18.0*** 15.8-20.6 
  $25,000-$34,999 1,663 20.8*** 17.6-24.5  1,834 17.9*** 15.0-21.3  1,816 21.4*** 18.1-25.2  2,116 24.4*** 20.9-28.3  2,373 19.5*** 16.3-23.1 
  $35,000-$49,999 1,445 20.0*** 16.8-23.7  1,479 22.2*** 18.5-26.5  1,578 27.0*** 22.6-32.0  1,741 23.3*** 19.8-27.1  1,961 19.4*** 16.1-23.3 
  $50,000-$74,999 905 22.9** 17.9-28.8  1,031 20.8*** 17.1-25.1  1,116 21.8*** 17.8-26.4  1,294 26.1*** 21.3-31.6  1,470 18.3*** 15.0-22.1 
   ≥$75,000 664 19.9*** 15.4-25.3  833 23.5*** 18.2-29.8  1,033 25.5*** 20.8-30.8  1,208 32.7*** 27.7-38.1  1,456 15.1*** 12.4-18.3 
                    
Education                    
  < High School  3,960 23.2*** 20.6-26.0  3,959 22.5*** 20.0-25.2  4,574 22.5*** 20.3-24.8  5,550 23.6*** 21.5-25.9  5,967 19.9*** 17.8-22.1 
  HS or GED 3,884 21.9*** 19.5-24.4  4,016 20.5*** 18.4-22.9  4,259 25.1*** 22.4-27.9  4,958 24.2*** 21.9-26.7  5,620 19.0*** 16.9-21.2 
  1-3 Years College 2,866 24.0*** 21.2-27.0  2,925 18.8*** 16.3-21.7  3,091 22.6*** 19.9-25.4  3,417 25.1*** 22.1-28.4  3,837 17.8*** 15.6-20.2 
  ≥ 4 Years College 2,171 22.6*** 19.5-25.9  2,416 22.5*** 19.7-25.5  2,676 23.7*** 21.0-26.8  2,964 27.8*** 24.9-31.0  3,160 20.3*** 17.5-23.3 
                    
Healthcare Coverage                   
  Yes 9,996 26.0*** 24.3-27.8  10,000 25.2*** 23.5-27.0  10,817 27.4*** 25.7-29.1  12,171 29.2*** 27.5-30.9  12,944 22.2*** 20.7-23.7 
  No 2,895 15.5* 13.4-17.8  3,304 12.8 11.0-14.8  3,770 15.6 13.7-17.7  4,707 16.0*** 14.2-17.9  5,648 13.9*** 12.1-15.8 
                    
* p < 0.05; **p < 0.01; ***p < 0.001. 
†=p value from difference of proportion test (non-Hispanic white vs. Hispanic). 
n= unweighted sample size. 
CI = confidence interval. 
% and CI are calculated from weighted values. 
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TABLE 10 continued. Influenza Vaccination Coverage for Hispanics Age ≥ 18 in the United States, 2000-2009 Flu Seasons 
Characteristics 
 
2005 Flu Season 
 
 2006 Flu Season  2007 Flu Season  2008 Flu Season  2009 Flu Season 
 n % C.I.  n % C.I.  n % C.I.  n % C.I.  n % C.I. 
Age                    
   18-24 1,716 17.9 14.3-22.2  1,879 21.8 18.4-25.7  1,582 20.7 17.2-24.7  1,491 21.7 18.3-25.5  1,491 23.0 18.9-27.7 
   25-34 4,031 12.8*** 11.1-14.8  4,396 17.5*** 15.4-19.9  3,834 16.4*** 14.3-18.7  3,638 19.1*** 17.0-21.4  3,435 21.7*** 19.4-24.2 
   35-44 4,031 15.7*** 13.3-18.4  4,724 20.4*** 18.3-22.7  4,456 19.5*** 17.5-21.6  4,545 20.6*** 18.6-22.7  4,626 24.7*** 22.7-26.8 
   45-54 4,249 17.6*** 15.2-20.4  4,141 24.1*** 21.5-26.8  3,940 25.0*** 22.5-27.7  4,164 27.3*** 24.9-29.8  4,425 27.5*** 25.4-29.8 
   55-64 3,377 30.2*** 26.4-34.4  3,214 35.3*** 31.8-39.0  3,129 34.7*** 31.6-38.1  3,472 39.4*** 36.2-42.6  3,746 38.3*** 35.5-41.1 
   ≥65 2,716 55.8*** 51.5-60.0  3,734 55.1*** 51.3-58.8  3,807 59.1*** 56.0-62.2  4,243 58.0*** 55.1-60.9  4,650 50.1*** 47.4-52.8 
                    
Sex                    
  Male 6,971 20.5*** 18.4-22.7  7,873 23.3*** 21.4-25.2  7,555 23.7*** 21.9-25.6  7,760 24.5*** 22.8-26.3  7,943 25.1*** 23.3-27.0 
  Female 12,190 20.2*** 18.8-21.7  14,333 26.4*** 25.0-27.9  13,305 25.2*** 23.8-26.7  13,875 28.7*** 27.3-30.2  14,472 30.5*** 29.2-31.9 
                    
Household Income                    
  ≤$14,999 4,215 20.0*** 17.0-23.3  4,328 24.0*** 21.1-27.1  4,325 25.2*** 22.4-28.2  4,819 26.1*** 23.5-28.9  4,979 23.6*** 21.5-25.9 
  $15,000-$24,999 4,763 19.5*** 16.9-22.4  5,208 22.9*** 20.6-25.3  5,178 22.2*** 19.9-24.8  5,053 24.5*** 22.4-26.8  5,160 24.3*** 22.3-26.5 
  $25,000-$34,999 2,320 17.1*** 13.9-20.7  2,694 24.1*** 20.6-27.9  2,516 23.0*** 20.1-26.2  2,508 22.7*** 20.0-25.7  2,536 27.9*** 23.4-32.8 
  $35,000-$49,999 1,916 19.7*** 16.5-23.3  2,502 22.3*** 19.2-25.8  2,236 24.0*** 20.7-27.5  2,226 28.8*** 25.3-32.7  2,334 29.7*** 26.2-33.4 
  $50,000-$74,999 1,494 19.9*** 16.5-24.0  1,929 24.4*** 20.2-29.1  1,785 26.7*** 22.9-30.9  1,821 27.1*** 23.8-30.7  1,820 31.1*** 27.4-35.1 
   ≥$75,000 1,711 23.3*** 19.4-27.7  2,258 28.9*** 25.5-32.5  2,112 26.0*** 22.9-29.3  2,417 31.3*** 28.2-34.6  2,487 37.9*** 34.7-41.1 
                    
Education                    
  Less than HS  6,106 19.0*** 16.7-21.4  6,844 22.3*** 20.2-24.6  6,712 23.9*** 21.8-26.1  6,531 26.3*** 24.2-28.5  6,917 25.0*** 22.8-27.3 
  HS or GED 5,571 19.8*** 17.7-22.2  6,526 25.6*** 23.4-28.0  6,104 24.5*** 22.3-26.9  6,182 23.7*** 21.7-25.8  6,343 26.4*** 24.3-28.5 
  1-3 Yrs. College 3,825 21.8*** 18.8-25.0  4,582 24.2*** 21.6-26.9  4,227 22.8*** 20.4-25.3  4,707 28.7*** 26.2-31.3  4,661 28.1*** 25.8-30.6 
  4(+) Yrs. College 3,595 22.3*** 19.5-25.4  4,135 28.5*** 25.8-31.3  3,761 27.5*** 24.9-30.3  4,154 29.0*** 26.6-31.5  4,423 34.0*** 31.6-36.5 
                   
Healthcare Coverage                   
  Yes 13,842 24.9*** 23.4-26.6  15,757 28.6*** 27.1-30.2  15,458 29.4*** 27.9-30.8  16,301 31.8*** 30.4-33.2  16,591 32.4*** 31.0-33.8 
  No 5,257 12.1** 10.0-14.5  6,370 16.8 15.0-18.7  5,353 14.7** 12.8-16.7  5,276 15.5** 13.8-17.3  5,761 17.6 15.8-19.6 
                    
* p < 0.05; **p < 0.01; ***p < 0.001. 
†=p value from difference of proportion test (non-Hispanic white vs. Hispanic). 
n= unweighted sample size. 
CI = confidence interval. 
% and CI are calculated from weighted values. 
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Odds of vaccination steadily increase with advancing age, with a dramatic jump 
being observed among males ≥65. In this age group, males experience nearly 70 percent 
(p <.001) absolute higher odds of reporting a flu vaccination than those aged 55 through 
64, and nearly 87 percent (p < .001) absolute greater odds of reporting a vaccination than 
the youngest age category, 18 through 24. Model 1 also indicates that vaccination rates 
are increasing throughout the period of observation.  
In Model 2, the presence of some form of healthcare coverage is added into the 
regression model. The inclusion of healthcare reduces the disparity between Hispanic and 
white males considerably, with Hispanic males now experiencing 15.2 percent (p <.001) 
absolute lower odds of vaccination than white males. Healthcare coverage is found to 
double the odds of reporting an influenza vaccination (p <.001). As observed in Model 1, 
the odds of reporting a vaccination continue to have a strong association with increasing 
age, regardless of healthcare coverage or race/ethnicity.  
 In Model 3, education and household income are introduced into the logistic 
regression model. When controlling for healthcare coverage, education, and household 
income, Hispanic males experience only 11 percent absolute lower odds of vaccination 
than white males (p <.001). Age continues to play a similar role as exhibited in Models 1 
and 2.  
Health care coverage continues to have the most influence in affecting odds of 
reporting a received flu vaccination, with odds being more than double for those with 
healthcare coverage than without (p <.001). 
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Statistically significant differences by education are also observed, with odds of 
reporting a vaccination increasing with education. Males with ≥4 years of college 
experienced significantly higher odds of reporting an influenza vaccination than those 
reporting an education level of less than high school. Interestingly, income appears to 
TABLE 11. Logistic Regression Estimates of the Effect of White and Hispanic Race/Ethnicity 
and Sociodemographic Factors on Reported Influenza vaccinations for US Males Age ≥ 18, 
 2000-2009 Flu Seasons. 
          
Characteristics 
Model 1  Model 2  Model  3 
AOR‡ 95% CI‡  AOR 95% CI  AOR 95% CI 
Race/ethnicity            
     White 1.000    1.000    1.000   
     Hispanic 0.747*** 0.719 0.777  0.848*** 0.815 0.882  0.891*** 0.854 0.930 
Age            
     ≥65 1.000    1.000    1.000   
     55-64 0.299*** 0.292 0.307  0.315*** 0.307 0.324  0.307*** 0.298 0.316 
     45-54 0.156*** 0.152 0.160  0.166*** 0.161 0.170  0.160*** 0.155 0.165 
     35-44 0.115*** 0.112 0.118  0.124*** 0.120 0.127  0.120*** 0.116 0.124 
     25-34 0.100*** 0.096 0.103  0.112*** 0.108 0.116  0.109*** 0.105 0.113 
     18-24 0.112*** 0.107 0.117  0.132*** 0.125 0.138  0.134*** 0.127 0.142 
Healthcare Coverage           
    No     1.000    1.000   
    Yes     2.139*** 2.057 2.224  2.048*** 1.960 2.139 
Education            
     < High School         1.000   
     High School         1.101*** 1.050 1.156 
     1-3 Years College        1.204*** 1.146 1.264 
     ≥ 4 Years College        1.469*** 1.400 1.540 
Household Income           
     ≤ $14,999          1.000   
     $15,000-$24,999        1.034 0.977 1.095 
     $25,000-$34,999        0.965 0.911 1.022 
     $35,000-$49,999        0.921** 0.872 0.972 
     $50,000-$74,999        0.918** 0.870 0.969 
     ≥ $75,000        1.006 0.954 1.060 
Period             
    2000-2009  1.036*** 1.033 1.040  1.037*** 1.034 1.041  1.037*** 1.033 1.041 
             
Valid n.
§
  834,633    832,314    752,672   
             
* p <0.05; **p <0.01; ***p <0.001. 
‡ AOR, adjusted odds ratio; CI, confidence interval. 
§ Unweighted sample size. 
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have a weak and counterintuitive effect on vaccination among males, where higher levels 
of household income fail to provide any benefit. Rather, four of the six income categories 
do not differ statistically in their impact on vaccination than the reference group 
(≤$14,999), while the other two ($35,000 through $49,000 and $50,000 through $74,999) 
experienced significantly lower odds of receiving a flu vaccination than those households 
with an income of ≤$14,999.  
 
Odds of Reporting Influenza Vaccination: Females 
  When performing the same series of logistic regressions among white and 
Hispanic females, similar findings were obtained as males, with some notable exceptions.  
First, in Model 1 of Table 12, when controlling for race/ethnicity and age, Hispanic 
females experienced 34.6 percent (p <.001) lower odds of reporting an influenza 
vaccination than white females. This is a considerably wider disparity than the 25.3 
percent lower odds of vaccination reported by Hispanic males. Age appears to have a 
similar effect for females as for males, with higher vaccination rates being associated 
with advancing age.  
 After introducing healthcare coverage into the logistic regression in Model 2, 
disparities between white and Hispanic females narrowed considerably. Having some 
form of healthcare coverage among females has similar effects in influencing the odds of 
reporting an influenza vaccination as with males, with healthcare more than doubling a 
woman‘s odds of reporting an influenza vaccination (p < .001). Age continues to have a 
similar effect as in Model 1, with odds of reporting vaccination increasing across all age 
groups. 
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Model 3 retained the previous variables and introduced education and household 
income into the analysis. In this model the disparity in odds ratios between white and 
Hispanic females narrowed even further. Education among females had similar effects as 
with males; as the respondent acquired more education, the odds of reporting a flu 
vaccination also increased. Females with ≥4 years of college experienced 38.3 percent 
higher (p <.001) odds of reporting an influenza vaccination when compared to females 
with less than high school. Income among females appears to increase the odds of 
vaccination along a gradient, with the odds of reporting a flu vaccine increasing with 
household income. It is interesting that among females, increasing household income did 
have the expected effect of increasing the odds of vaccination. This effect was not 
observed among males, which suggests that while household income may be an 
important determinant of vaccination among females it is less so for males. Females 
reporting some form of healthcare coverage in this model reported 89.3 percent higher 
absolute odds of receiving an influenza vaccination than females without some form of 
healthcare coverage (p <.001). As with all previous models, age continues to have a 
statistically significant effect in the odds of receiving a flu vaccination, with females  ≥65 
experiencing, in absolute terms, 63.9 percent higher odds of reporting a vaccination than 
females 55 through 64 and 88.3 percent higher than females aged 18 through 24. 
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TABLE 12. Logistic Regression Estimates of the Effect of White and Hispanic Race/Ethnicity 
and Sociodemographic Factors on Reported Influenza vaccinations for US Females Age ≥ 18, 
 2000-2009 Flu Seasons. 
          
Characteristics 
Model 1  Model 2  Model  3 
AOR‡ 95% CI‡  AOR 95% CI  AOR 95% CI 
Race/ethnicity            
     White 1.000    1.000    1.000   
     Hispanic 0.654*** 0.635 0.674  .731*** 0.709 0.754  0.806*** 0.780 0.833 
Age            
     ≥ 65 1.000    1.000    1.000   
     55-64 0.373*** 0.365 0.380  0.396*** 0.388 0.404  0.361*** 0.353 0.370 
     45-54 0.205*** 0.201 0.209  0.217*** 0.213 0.222  0.193*** 0.188 0.198 
     35-44 0.142*** 0.138 0.145  0.151*** 0.148 0.155  0.132*** 0.128 0.135 
     25-34 0.124*** 0.121 0.127  0.136*** 0.133 0.139  0.119*** 0.116 0.123 
     18-24 0.109*** 0.105 0.113  0.124*** 0.119 0.129  0.117*** 0.112 0.123 
Healthcare Coverage           
    No     1.000    1.000   
    Yes     2.126*** 2.062 2.192  1.893*** 1.829 1.960 
Education            
     < High School         1.000   
     HS or GED         1.028 0.991 1.067 
     1-3 Years College        1.160*** 1.117 1.204 
     ≥ 4 Years College        1.383*** 1.331 1.437 
Household Income           
     ≤ $14,999          1.000   
     $15,000-$24,999        1.083*** 1.046 1.121 
     $25,000-$34,999        1.108*** 1.069 1.149 
     $35,000-$49,999        1.103*** 1.065 1.143 
     $50,000-$74,999        1.123*** 1.084 1.164 
     ≥ $75,000        1.249*** 1.204 1.295 
Period             
    2000-2009  1.057*** 1.055 1.060  1.058*** 1.055 1.061  1.057*** 1.054 1.060 
             
Valid n.
§
  1,325,609   1,323,345   1,123,506  
* p <0.05; **p <0.01; ***p <0.001. 
‡ AOR, adjusted odds ratio; CI, confidence interval. 
§ Unweighted sample size. 
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CHAPTER VI 
DISCUSSION 
 
 As demonstrated through the analyses, statistically significant differences in 
vaccination uptake among whites and Hispanics were present in the United States during 
the 2000 through 2009 flu seasons. Consistently, Hispanics reported lower rates of 
influenza vaccination than their white counterparts. While influenza vaccinations have 
been increasing for both groups, the difference in the rate of increase has led to a 
widening disparity between whites and Hispanics during the period of observation. 
Findings from this study lend support to the proposition set forth by FCT that whites are 
better able to utilize flexible resources to obtain better health. Specifically, the presence 
of some form of healthcare is very influential in predicting the odds of reporting a 
seasonal influenza vaccination. During the ten-season period of observation, 89.1 percent 
(95 percent CI, 89.0 through 89.2) of whites reported some form of healthcare coverage 
compared to 66.8 percent (95 percent CI, 66.3 through 67.3) of Hispanics, highlighting 
the considerable gap in healthcare coverage between the two groups. This large disparity 
in healthcare coverage indicates that whites may be able to utilize more medical 
resources than Hispanics to obtain influenza vaccinations, supporting the claim of FCT 
that racial and ethnic minorities may be disadvantaged in the utilization of flexible 
resources to improve health. Even though flu vaccinations are relatively inexpensive 
without insurance and increasingly available in non-traditional locations (such as 
shopping centers), the effect of healthcare coverage on the odds of reporting vaccination 
was relatively stable even when controlling for the possible confounding effects of 
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household income and education. While not explaining the entirety of the difference in 
adjusted odds ratios, socioeconomic factors such as healthcare coverage, education, and 
household income explained 56.9 percent and 43.9 percent of the absolute difference in 
odds ratios for Hispanics males and females, respectively, relative to their white 
counterparts in reporting a seasonal influenza vaccination.  
Importantly, the presence of healthcare coverage had a dramatic effect on the 
receipt of an influenza vaccination. As shown in the analyses, both whites and Hispanics 
reporting some form of health care coverage experienced dramatically higher rates of 
influenza vaccination than those without. Given the differences between those with or 
without some form of healthcare coverage, it is no surprise that it produced the largest 
effect in the logistic regression models. This finding is encouraging as programs aimed at 
increasing healthcare coverage among Hispanics may be influential in reducing 
disparities in flu vaccination.  
Between whites and Hispanics one of the most important gaps in coverage 
appears in the ≥65 age group. On average, Hispanics ≥65 experienced vaccination rates 
nearly 15 percent lower than their white counterparts, with the disparity being its widest 
during the 2009 influenza season. Seasonal influenza vaccination is an important step in 
preventing both illness and mortality, especially among older individuals (Thompson et 
al. 2004). Given that individuals ≥65 experience the highest mortality rates due to 
seasonal influenza, addressing racial/ethnic vaccination disparities in this age group 
should be a critical public health concern. Also, the large disparity between whites and 
Hispanics in this vulnerable age group support the argument presented in Fiscella et al. 
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(2007) that eliminating vaccination disparities among older Americans would result in 
more than 33,000 years of life saved among racial and ethnic minorities. 
 However, optimistically, it should be noted that for all four demographic groups 
considered in this paper (e.g., white females); the odds of reporting a seasonal influenza 
vaccination were highest among those ≥65. This could be due to the success of public 
health information campaigns informing individuals  ≥65 of the risks of the seasonal 
influenza and the benefits of vaccination. Another explanation could be that Medicare 
coverage, which begins at age 65 and covers the cost of the seasonal influenza vaccine, 
increases odds of vaccination. Furthermore, by having some form of healthcare coverage 
(such as Medicare), individuals ≥65 may have greater access to healthcare knowledge, 
increasing their ability to utilize flexible resources to improve health. 
 
Limitations 
 While FCT does provide a useful theoretical perspective in explaining health 
inequalities, controlling for SES as measured in this study did not completely eliminate 
disparities between whites and Hispanics. However, it should be recognized that there are 
more characteristics and attributes than healthcare coverage, education, and household 
income that could be included in measuring flexible resources as defined by FCT (Link 
and Phelan 1995). For example, primary language, proximity to health care facilities, and 
social connections could all be measures of flexible resources as described by FCT that 
could affect seasonal influenza vaccination rates (Phelan et al. 2004), but are not included 
in this thesis due to data limitations. 
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 An important flexible resource mentioned in FCT that is not included in the 
analyses is ―knowledge‖ and ―beneficial social connections‖ (Link and Phelan 1995). As 
mentioned in Chen et al. (2007), among Hispanics the most common explanation given 
for not receiving the flu shot was that it was not needed. Employing a Health Belief 
Model (HBM) approach to explaining vaccination disparities, it would seem that the 
perceived susceptibility and perceived severity of seasonal influenza is not great enough 
among Hispanics to warrant vaccination (Champion and Skinner 2008). The lack of 
information within the BRFSS regarding attitudes towards seasonal influenza prevents 
the test of an HBM explanation of vaccination disparities. Even without including the 
respondents‘ attitudes toward vaccination, sociodemographic characteristics did help 
explain much of the gap between non-Hispanic whites and Hispanics in the odds of 
reporting receipt of a vaccine. Nevertheless, because Hispanic attitudes toward 
vaccination are potentially important in generating ethnic disparities, this issue merits 
additional consideration in future research. 
 Another notable limitation is the methodology used in gathering data for the 
BRFSS. For nearly all waves of the BRFSS, data were primarily collected through 
landline telephone numbers. It was not until the 2009 BRFSS that a dual-frame design 
was introduced to help capture both landline telephone respondents and cellular phone 
users (ABT Associates 2011). It has been noted that landline telephone surveys may 
artificially inflate influenza vaccination rates due to selection biases that favor the 
inclusion of advantaged socioeconomic groups (Blumberg and Luke 2007). Given the 
high percentage of Hispanics with lower incomes, actual influenza vaccination rates are 
likely to be somewhat lower than the estimates generated through this investigation. 
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CHAPTER VII 
CONCLUSION 
 
Seasonal influenza produces serious epidemics that cause substantial economic, 
mortality, and morbidity burdens in the United States every year. Tens of thousands of 
deaths, hundreds of thousands of hospitalizations, and billions of dollars lost is the typical 
result of seasonal influenza (Thompson et al. 2004; Molinari et al. 2007; CDC 2010a). 
Through effective vaccination, these burdens can be significantly reduced (Nichol 2008). 
However, substantial disparities in influenza vaccination rates have been observed 
between disadvantaged racial/ethnic and socioeconomic groups, and their more 
advantaged counterparts (Lu et al. 2008). Addressing such disparities is an important step 
toward reducing the disease burden of seasonal influenza.  
In order to create effectual programs in eliminating disparities in seasonal 
influenza vaccinations, accurate information regarding long-term seasonal influenza 
vaccination trends must be obtained. Unfortunately, somewhat imprecise language in the 
measure of influenza vaccination status in the BRFSS (asking if in the last 12 months the 
respondent received a vaccination) limits the accuracy of seasonal estimates. Even with 
the addition of a follow-up question asking the specific month and year of the last 
reported vaccination, information regarding the non-vaccination behavior of respondents 
is unavailable, limiting the analysis of possible disparities. 
However, this thesis finds that substantial gains in accuracy can be made when 
estimating seasonal influenza vaccination rates by restricting respondents to those 
interviewed from January through September. By doing so, a more accurate sample is 
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produced whereby rates of vaccination for the previous year‘s flu season can be 
estimated. The effectiveness of this method can be seen when observing both the 
Behavioral Risk Factor Surveillance System (BRFSS) and the National Health Interview 
Survey (NHIS). While differing substantially in their survey methodology, restricting 
respondents by survey months January through September in the BRFSS or first quarter 
through third quarter in the NHIS proved effective in producing samples which were not 
only more representative of the previous year‘s flu season, but also retained a higher 
percentage of respondents than previous methods. The technique first presented in Burger 
et al. (forthcoming) and elaborated in this thesis could be used by health agencies at the 
local, state, and national level to track influenza vaccination coverage by 
sociodemographic subgroups, helping to identify potential disparities. This information 
would prove valuable in focusing public health policy to increase vaccination among 
disadvantaged groups.  
Utilization of the method elaborated upon in this thesis provides a reliable 
framework to examine seasonal trends in influenza vaccination by known and possible 
risk factors (such as obesity, diabetes, and chronic disease) and other sociodemographic 
characteristics (such as urban/rural differences in vaccination). Furthermore, the Burger 
et al. (forthcoming) method is a viable solution for tracking seasonal influenza 
vaccinations within the BRFSS and the NHIS, opening more avenues for future research. 
However, it should be noted that such data manipulation would be unnecessary if 
the way in which the BRFSS and NHIS measured seasonal influenza vaccination were 
changed. Following an approach found in the National Flu Survey (CDC 2010h), asking 
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respondents if they have received an influenza vaccination during a specific flu season 
could yield more accurate results.  
 
Policy Implications 
This thesis shows that from the 2000 through 2009 flu seasons, Hispanics often 
reported receiving influenza vaccinations at lower rates than whites. In nearly every 
sociodemographic category (age, sex, presence of healthcare coverage, education, and 
household income) statistically significant disparities existed between the two groups 
during each period of observation. However, the analyses in this thesis suggest that 
sizable reductions in racial/ethnic disparities in influenza vaccination rates can be 
achieved by improving access to health care coverage, as well the education and 
household income levels of Hispanics. The role of some form of healthcare coverage was 
found to produce the greatest gains in improving the odds of reporting an influenza 
vaccination. This research suggests that by addressing the issue of low healthcare 
coverage among Hispanics, an increase in reported flu vaccinations could occur. Citing 
the Massachusetts healthcare reform passed in 2006, the CDC (2010f) notes that after the 
legislation (which provided nearly universal healthcare coverage for state residents) 
dramatic increases were observed among segments of the population that traditionally 
reported low levels of coverage. These increases included gains among Spanish-speaking 
Hispanics (30.3 percent increase) and Hispanics overall (14.2 percent increase), ―persons 
with less than a high school diploma (12.0 percent increase), and persons with annual 
household incomes <$25,000 (11.9 percent increase)‖ (263). Given that all of these 
subgroups experienced lower vaccination rates within and between white and Hispanic 
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race/ethnicity, increasing healthcare coverage is likely to increase the odds of receiving a 
seasonal influenza vaccination for each group. It is expected that similar results could be 
seen throughout the United States with national healthcare reform or a reduction in the 
cost of adequate health care coverage. Future research comparing influenza vaccination 
rates among these groups in Massachusetts with the rest of the United States could reveal 
the actual impact of such legislation.  
Addressing racial/ethnic disparities in influenza vaccination coverage could 
potentially reduce the disease burden of seasonal influenza in the United States, while 
also contributing to the achievement of prominent public health objectives. By focusing 
on policies aimed at providing and improving access of healthcare coverage (and 
improving the overall socioeconomic condition of Hispanics in the United States), 
elimination of the fundamental causes of health disparities could produce significant 
gains in seasonal influenza vaccinations, reducing the disease burden of seasonal 
influenza.  
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